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CONSTRUCTION OF GFP BASED DESIGNER PROTEINS 
SUMMARY 
In nanotechnological applications, peptide and protein related materials are exploited 
as smart building blocks. In nature, molecular recognition based functions are a key 
role in evolution, sequential cycles of mutation and selection are part of improved 
progeny. In nature there are various examples of functional biological materials and 
systems that proteins control the formation and the morphology of inorganics. 
In recent years, not only in hard tissue engineering but also in producing advance 
materials and systems, biomimetic synthesis and formation of inorganics using 
biological routes have attracted a great interest. In this study, we focus on addressing 
biological routes for materials labelling and assembly using genetically engineered 
proteins. We designed multifunctional  proteins that can target inorganic materials 
specifically and still carry their biological functionality. Here, we selected two 
different case study based on calcium phosphate mineral, and metal surface/NP 
interactions through designing engineered green fluorescence proteins.  
Calcium phosphate based biomineralization is studied extensively due to its key role 
in the bone and dental hard tissue formation. We therefore,  designed a protein based 
system that can target calcium phosphate minerals and allows monitoring of 
biomineralization, namely  GFPuv-HABP.  Fluorescence and binding activities of bi-
functional proteins were characterized using fluorescence microscopy and 
spectroscopy, and quartz crystal microbalance system, respectively. The utility of 
GFPuv-HABP1 fusion protein was assessed for both time-wise mineralization 
monitoring and visualization of mineralized tissues.  
In biotechnology, site-specific protein immobilization is required for the fabrication 
of efficient tools such as protein chips, biosensors and microarrays. The conventional 
methods, including physical and chemical immobilizations are also applicable for 
protein immobilization. However, these approaches may cause a decrease in protein 
activity due to the uncontrolled assembly following interaction between functional 
groups of the protein and the surface. Here we employed peptide based assembly 
where inorganic binding peptides were used for the directed immobilization of a 
functional protein GFPuv on silver and gold substrates with different forms, as flat 
surfaces and nanoaprticles. The correlation between the binding of bifunctional 
proteins to nanoparticles and fluorescence quenching/enhancement efficiency was 
evaluated.  
Finally, we demonstrated that genetically engineered peptides for inorganics (GEPI) 
can be inserted into functional proteins and GEPI-GFP can be used in diverse areas 
from labelling minerals to quenching flurorescence activity in a controlled manner. 
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GFP BAZLI TASARIM PROTEİNLERİNİN OLUŞTURULMASI 
ÖZET 
Nanoteknolojik uygulamalarda, peptit ve proteinlerle ilgili malzemeler akıllı 
yapıtaşları olarak kullanılırlar. Doğada moleküler tanımaya dayalı işlevler evrimde 
anahtar bir rol alırlar, ardışık mutasyon ve seçilim döngüleri iyileştirilmiş neslin  bir 
parçasıdır. Doğada proteinlerin anorganiklerin oluşumunu ve morfolojisini kontrol 
ettiği pek çok işlevsel biyolojik malzeme ve sistem örneği vardır.  
Son yıllarda, yalnızca sert doku mühendisliğinde değil, aynı zamanda ileri malzeme 
ve sistemlerin üretiminde, anorganiklerin biyolojik yolla biyobenzetimsel sentez ve 
oluşumu oldukça ilgi çekmektedir. Bu çalışmada, genetik mühendisliği ile 
iyileştirilmiş proteinlerin malzemenin etiketlenmesi ve kurulumu için biyolojik 
yollara yönelmeye odaklandık. Anorganik malzemeyi özgül olarak hedefleyen ve 
biyolojik fonksiyonlarını hala sürdüren multifonksiyonel proteinler tasarladık. 
Burada, genetik mühendisliği uygulanmış yeşil floresan proteinlerinin tasarlamasıyla, 
kalsiyum fosfat mineral ve metal yüzey/nanopartikül etkileşimlerine dayalı iki farklı 
durum çalışması seçtik.  
Kalsiyum fosfat bazlı biyomineralizasyon, kemik ve diş sert dokularının 
oluşumundaki anahtar rolü nedeniyle yaygın olarak çalışılmıştır. Bu nedenle, 
kalsiyum fosfat minerallerini hedefleyen ve biyomineralizasyonun görüntülenmesini 
mümkün kılan protein bazlı bir sistemi yani GFPuv-HABP’yi tasarladık. Çift 
fonksiyonlu proteinlerin floresan ve bağlanma aktiviteleri, sırasıyla floresan 
mikroskopi ve spektroskopi ile kuartz kristal mikrobalans sistemi kullanılarak 
karakterize edilmiştir. GFPuv-HABP1 füzyon proteinin kullanımı, zamansal 
mineralizasyonu izleme ve mineralleşen dokuların görüntülenmesi açısından 
değerlendirilmiştir. 
Biyoteknolojide, bölgeye özgül protein immobilizasyonu protein çipleri, 
biyosensörler ve mikroarrayler gibi etkin araçların üretiminde gereklidir. Fiziksel ve 
kimyasal immobilizasyonu kapsayan geleneksel yöntemlerin, protein 
immobilizasyonu için de uygulanabilirliği vardır. Ancak, bu yaklaşımlar, proteinin 
fonsiyonel gurupları ile yüzey arasındaki etkileşimleri izleyen kontolsüz toplanma 
sebebiyle protein aktivitesinde düşüşe neden olabilir. Burada, anorganiklere bağlanan 
peptidlerin, fonksiyonel protein GFPuvnin düz yüzey ya da nanopartikül şeklinde 
farklı formlardaki gümüş ve altın substrata immobilizasyonunda kullanılmasında, 
peptit bazlı kurulumdan faydalanılmıştır. Bifonksiyonel proteinlerin nanopartiküllere 
bağlanması ve floresan sönüm/artma etkinliği arasındaki korelasyon 
değerlendirilmiştir. 
Son olarak, genetik mühendisliği ile iyileştirilmiş anorganiklere bağlanan peptitlerin 
(GEPI) fonksiyonel proteinlere yerleştirilebileceğini, GEPI-GFP’nin kontrollü 
biçimde, minerallerin etiketlenmesinden floresan sönme aktivitesine kadar çeşitli 
alanlarda kullanılabileceğini gösterdik.  
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1.  INTRODUCTION 
1.1 Nano- and Bionanotechnology 
Nanotechnology was first introduced by Nobel laureate Richard P. Feynman (1959) 
in his lecture, “There’s Plenty of Room at the Bottom”. Since his consideration for 
the possibility of direct manipulation of individual atoms, there have been many 
critical developments in physics, chemistry, and biology that have represented 
Feynman’s vision. This vision also paved the way first towards biomimetic material 
processing, then using biology as a guide to realize nanotechnology (Sarikaya and 
Aksay, 1995, Mann, 1996, Sarikaya, 1999, Whaley et al., 2000). 
The specificity and the recognition funcions of peptide and protein based materials 
are exploited as building blocks in nanotechnology to fabricate useful functional 
structures and devices (Woodbury et al., 1998, Sarikaya, 1999, Brown, 2001, 
Sarikaya  et al., 2003, Sarikaya et al., 2004, Kacar et al., 2009a). Nanotechnology has 
been commonly defined as “the understanding, control, and restructuring of matter 
on the order of nanometers to create materials with fundamentally new properties 
and functions”. “Topdown” and “bottom-up” approaches are the two main 
approaches in nanotechnology . There is not any atomic level control for topdown 
approach. In this approach, structures are reduced to nanoscale size and the original 
properties of matter are maintained. The “bottom-up” approach is also called as 
molecular nanotechnology or molecular manufacturing. In this approach, materials 
are engineered by assembly or self-assembly mechanism from atoms or molecules 
(Drexler, 1995, Sanchez and Sobolev, 2010). Bionanotechnology is the integration of 
biology and nanotechnology. Molecular biomimetics, proposed by Sarikaya et al., 
can be considered as a promising path to realizing nano- and bionanotechnology. In 
molecular biomimetics, hybrid technologies are developed by using the tools of 
molecular biology and nanotechnology (Sarikaya, 1999, Sarikaya et al., 2003, 
Tamerler et al., 2010). 
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Engineering materials at molecular level is possible by exploiting molecular 
biomimetics. Short amino acid sequences that can specifically bind to inorganics and 
be selected using combinatorial techniques can be further engineered. These small 
peptides can be synthesized easily by chemical and genetic engineering procedures 
and they became an important component of the bionanotechnological studies 
(Sarikaya, 1999, Sarikaya et al., 2003, Tamerler and Sarikaya, 2009a).  
1.2 Lessons From Nature  
Proteins are the major building blocks of biological systems from the simplest forms 
to mammalian species. Specific interactions of these building blocks sustain the 
viability of  organisms. Formation of controlled structures at all scales in the system 
depends on biomolecule-material interaction which is accomplished with molecular 
specificity and efficiency (Sarikaya et al., 2003, Tamerler and Sarikaya, 2009b, 
Tamerler et al., 2010).  
In traditional materials science engineering, materials are produced using a group of 
methods, including melting and solidification, thermomechanical treatments, 
solution/vacuum deposition and growth. In nature, molecular recognition and 
functions are tested, improved and developed by evolutionary selection process, 
sequential cycles of mutation and selection (Sarikaya et al., 2003).  
There are many examples in nature of functional biological materials and systems 
that proteins control the formation (Tamerler et al., 2010). A magnetotactic 
bacterium Aquaspirillum magnetotacticum which can sense the Earth’s magnetic 
field has a magnetic nanoparticle system (Figure 1.1A) incorporating aligned 
magnetosomes, protein and lipid based membrane compartments (Sarikaya et al., 
2004, Tamerler et al., 2010). 
The second example is mother of pearl, nacre, of seashells (Figure 1.1B). Nacre is a 
segmented laminated composite of aragonite (orthorhombic calcium carbonate) and 
biomolecules in the interior with superior mechanical properties. It is now possible to 
understand, engineer, and control peptide molecular recognition and peptide-material 
interaction (Tamerler et al., 2010). 
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Figure 1.1 : Functional biological materials systems. A) A magnetotactic 
bacterium Aquaspirillum magnetotacticum has a magnetic 
nanoparticle system B) Nacre of seashells. C) Mammalian tooth 
composed of enamel (E), dentin (D), pulp (P), cementum (C) and 
periodontal ligaments (Tamerler et al., 2010).  
The third example is enamel, the hardest material in the body, protecting the dental 
tissues. Enamel is integrated to the softer tissue dentin. Tougher bone-like tissue, 
enamel, prevents premature fracture or failure through absorbing energy during 
mastication and cutting. Hierarchically ordered woven structure of mammalian tooth 
enamel is controlled by proteins. This structure consist of thousands of 30 nm-
diameter, mm-long  hydroxyapatite (HA) crystallites (Figure 1.1C). More than 40 
different proteins are known to take part in the enamel formation. Studies on these 
proteins and understanding their effects on biofabrication of dental tissues would 
provide developments for regeneration or restoration of hard tissues including 
enamel (Fong et al., 2003, Tamerler et al., 2007a, Tamerler et al., 2010). 
Another example is an deep-sea sponce Rosella racovitzea which has silica based 
spicules that collect and transmit light effectively. The spicules’ star shaped tips 
collect light and the silica based optical fiber shaft transmits light 200 m under the 
ocean (Figure 1.2). Both parts of the spicules are composites of silica and proteins 
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that makes possible the structural and functional properties of the system (Tamerler 
et al., 2007b; Tamerler and Sarikaya, 2009a). 
 
Figure 1.2 : Spicules of Rosella rocavitzea are made of layered amorphous silica. 
The tip of the spicule is a star shaped lens (Tamerler and Sarikaya, 
2009a). 
1.3 Designing and Engineering of Proteins 
The diverse interactions between a variety of hydrophobic, polar and ionizable side 
chains of  proteins cause their structural and functional complexity. Therefore it is 
difficult to predict the structure and function of a protein from its primary sequence.  
The high amount of sequence information obtained from genome projects is 
available and it has been shown that abnormal protein structures give rise to certain 
diseases. The progress in protein structure and function research including these 
examples has led to new studies on designing proteins with desired properties. 
Research areas including knowledge-based structure prediction, protein stability, 
protein–protein and protein–ligand interactions, enzyme catalysis and protein design 
provide information about structure-function relationship and lead to new 
developments in protein science (Lilie, 2003).  
It is important to purify proteins in high amount for most applications ranging from 
biotechnology to medicine by using recombinant methods or by peptide synthesis  as 
many kinds of  proteins in their native sources are not aboundant enough to be 
extracted.  
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In the recombinant production approach, cloning strategies should be carefully 
chosen in order to make designed recombinant proteins which are well expressed in 
the host organism. In addition to this, proteins should be soluble form without any 
loss in original activity. Using Escherichia coli as a recombinant host is cost effective 
and provides the scalable and fast expression The process for obtaining a synthetic 
peptide starts with designing. Following this are the chemical synthesis, evaluation 
and purification steps (Grant, 2002). 
Creating designed interfaces using solid-binding peptides between biological and 
material sciences may provide opportunities for the fabrication of novel practical 
systems (Tamerler and Sarikaya, 2009a). Model of mutant pIII protein of M13 
phage, representing a functional protein containing a solid binding peptide 
(quartzbinding peptide) binding to  the surface (quartz (100)) is shown in Figure 1.3. 
 
Figure 1.3 : Model of a designed peptide. Mutant pIII protein of M13 phage, 
representing a functional protein containing a solid binding peptide 
(quartzbinding peptide) binding to  the quartz (100) surface (Tamerler 
and Sarikaya, 2009a). 
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1.4 Molecular Biomimetics 
Biomolecules, mainly proteins and  inorganic components are essential for synthesis, 
assembly and function of the section 1.2 given examples and other biological 
materials and hard tissues. Proteins control nucleation, growth and assembly of 
biological tissues at the nano, meso and macroscales. For understanding the 
biochemical and biophysical nature and the practical utilization of these proteins,  
studies on simple polypeptides with specific functions could be carried besides the 
genomic and proteomic research. With the new emerging field, molecular 
biomimetics, peptides can be selected and engineered to molecularly recognize the 
specific inorganic surface (Mayer and Sarikaya, 2002, Fong et al., 2003, Sarikaya et 
al., 2003, Sarikaya et al., 2004, Tamerler et al., 2007a, Tamerler and Sarikaya, 
2009b).  
With their highly controlled nonastructures, biocomposites have advantages over the 
synthetic structures (Lowenstam et al., 1984, Sarikaya, 1999, Ball, 2001). 
Researchers have been emulated or inspired from nature to design useful materials 
and systems generally using synthetic components and conventional methods in the 
traditional biomimetics approach (Mann, 1993, Seeman and Belcher, 2002). 
Molecular biomimetics, a promising route for material assembly, fabrication and 
application of technologically exquisite materials, has been an emerging field based 
on recent advances in molecular biology and engineering and physical sciences. In 
addition to traditional biomimetics aspects emulating or duplicating biosystems, it 
can be possible to engineer materials at molecular level based on molecular 
biomimetics approach (Sarikaya 1999, Seeman and Belcher, 2002, Sarikaya et al., 
2003, Tamerler et al., 2010). 
1.4.1 Inorganic binding peptides 
It is now possible to understand, engineer, and control peptide molecular recognition 
and peptide-material interaction. The utilization of combinatorial screening 
techniques has recently led to development of a large number of novel peptides that 
can specifically bind with inorganic substrate (Sarikaya et al., 2003, Tamerler et al., 
2010). 
Short peptides with specificity to a variety of materials have been selected through 
both cell surface or phage display methods. After selection, further experiments have 
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been applied to determine the binding kinetics and surface stability of these short 
peptides called as genetically engineered peptides for inorganics, i.e., GEPIs 
(Sarikaya et al., 2003, Tamerler et al., 2010).  
Peptide sequences that are specific to a myriad of inorganic materials including noble 
metals, e.g., gold (Brown et al., 2000, Huang et al., 2005, Hnilova et al., 2008), silver 
(Naik et al., 2002, Nam et al., 2008, Hnilova et al., unpublished data), and platinum 
(Seker et al., 2007)), oxides, e.g., SiO2 (Oren et al., 2007; Tamerler, 2007a), ZnO 
(Thai et al., 2004), Cu2O (Thai et al., 2004), TiO2 (Sano and Shiba 2003; Sano et al., 
2005, Dickerson et al., 2008), minerals, hydroxyapatite (Gungormus et al., 2008, Roy 
et al., 2008), calcite (Gaskin et al., 2000)), sapphire (Krauland et al., 2007)) and 
semiconductors (e.g., GaAs (Whaley et al., 2000), ZnS and CdS (Lee et al., 2002)) 
have been identified. 
1.4.1.1 Combinatorial selection  
Combinatorial selection techniques such as phage display (Smith 1985, Hoess, 2001) 
and cell surface display (Wittrup, 2001) have been exploited for various biological 
applications including identifying the ligands, mapping the molecular recognition 
site of the antibodies and indicating the affinity and specificity for a certain  
molecule in the design of new drugs and agents (Smith and Petrenko 1997, Petrounia 
and Arnold 2000, Benhar, 2001, Rosander et al., 2002).   
Combinatorial selection protocols can be used to select polypeptides that bind to the 
inorganics that have unique physical properties in nano and biotechnology. 
Oligonucleotides encoding random sequences of aminoacids are inserted into phage 
genomes or into bacterial plasmids for the generation of phage and cell surface 
display libraries. The randomized aminoacid sequences which are incorporated with 
proteins like the coat protein of the phage or the outer membrane or flagellar protein 
of a bacterium are expressed on the surface of the organism. Eventually, each 
organism produces different and random peptide (Brown et al., 2000; Whaley et al., 
2000). 
The mixture of recombinant cells or phages are exposed to the inorganic surface of 
interest. Following washing cycles to eliminate non-binder phages or cells, binders 
are eluted from the material surface. Weak interactions with the surface are disrupted 
during the washing step. After this step, phages and cells are amplified and a round 
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of biopanning is completed. To obtain strong binders three to five rounds are 
repeated (Tamerler and Sarikaya, 2008). After the biopanning rounds, clons carrying 
the peptides binding to the inorganic material are sequenced to obtain the DNA 
sequences (Figure 1.4). 
 
Figure 1.4 : Combinatorial selection of GEPIs (Tamerler and Sarikaya, 2008). 
Outer membrane proteins, lipoproteins,fimbria and flagellar proteins have been used 
for cell surface display while coat proteins are used for the phage display.  
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1.4.1.2 Molecular characterization of GEPIs 
Binding characteristics of GEPIs can be tested by microscopic or spectroscopic 
analyses such as fluorescence microscopy or surface plasmon resonance 
spectroscopy (SPR) and quartz crystal microbalance (QCM). SPR and QCM 
determine the specificity and kinetics of the molecular binding of  peptides to certain 
surfaces (Tamerler et al., 2006b, Seker et al., 2007, Tamerler et al., 2007a). These 
methods may have limitations for the studies on small molecules  (Bailey et al., 
2002). The detailed molecular structure of the inorganic binder peptides can be 
characterized by circular dichroism (CD) and nuclear magnetic resonance (NMR) 
spectroscopy (Kulp et al., 2004). In the Figure 1.5, CD and NMR data are shown for 
hydroxyapatite binding peptides, HABP1, HABP2 and 3 repeat gold binding 
peptides, 3rGBP1, respectively (Tamerler and Sarikaya, 2008). Another step for 
molecular characterization is computational modelling to understand the molecular 
conformation and mechanism of crystallographic surface recognition in the absence 
of the structural experimental data (Barth et al., 2005, Oren et al., 2007, Tomasio and 
Walsh, 2007). Supramolecular selfassembly and surface coverage of GEPIs can be 
visualised by atomic force microscopy (AFM). Quantitative data and nanostructure 
images obtained by AFM is important for specific application of GEPIs (Tamerler 
and Sarikaya, 2007a). 
 
Figure 1.5 : Molecular characterization of GEPIs. a) SPR and QCM determine 
the specificity and kinetics of the binding. b) The detailed molecular 
structure of the peptides. c) Computational modelling of GEPIs is 
necessary for understanding the molecular conformation and 
mechanism of crystallographic surface recognition. d) 
Supramolecular self assembly of gold binding peptide on graphite 
and Au (Tamerler and Sarikaya, 2008). 
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1.4.1.3 GEPI based bionanotechnological systems 
Binding, assembling, synthesizing and growing of the materials on the solid surfaces 
under desired conditions are important for many technological and medical 
applications ranging from biosensors to nanophotonics (Ginger et al., 2004, Chen et 
al., 2008, Wei et al., 2009). At this point, selection and optimization of the linking 
conditions for binding functional structures to a variety of different surfaces such as 
metals, oxides and semiconductors have come into prominence (Wei et al., 2009).  
There are a range of small molecules used in functionalizing of the surfaces, such as 
thiols for gold, silanes for silica or other oxides, and phosphonic acids for metal 
oxides. In recent years, the utility of peptides as a promissing technique for surface 
functionalization have become common (Hnilova et al., 2008; Kacar et al., 2009b).  
There is only limited understanding for the fundamental mechanisms of molecular 
binding to solids, assembly and the organization in spite of the recent developments 
and the extensive reports (Sarikaya, 1999, Evans et al., 2008, Tamerler et al., 2010). 
However, the data obtained from techniques like NMR spectroscopy (Kulp et al., 
2004), computational modeling  (Braun et al., 2002, Oren et al., 2005), and 
experiments with geometrically constrained peptides (Dai et al., 2005) have provided 
an oppurtunity for making suggestions about the mechanisms. In the light of these 
data it has been suggested that the secondary structures of the engineered peptides in 
solution can play an important role in their solid-binding and selectivity (Wei et al., 
2009). 
Many techniques including pin printing, inkjet printing, nanoimprint lithography, 
electron beam lithography, focused ion beam lithography, soft lithography, 
photolithography, scanning probe microscopy, and dip-pen nanolithography have 
been exploited for the patterning of biomolecules (Wilson et al., 2001; Noy et al., 
2002; Agarwal et al., 2003; Lee et al., 2003; Ginger et al., 2004; Cho and Ivanisevic 
2006). However, these biomolecules are not engineered for specific binding to target 
surface. Functions of the biomolecules are generally lost in the case of nonspecific 
binding. Solution-phase secondary structure of the solid binding peptides has a 
possible role in the affinity or selectivity for the given suface. Engineered solid 
binding peptides can be used as “viable inks” for a variety of immobilization 
approachs (Kacar et al., 2009b; Wei et al., 2009). 
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Further tailoring of the selected solid-binding peptides to improve their affinity and 
material-selectivity properties so that they can be used in biofunctionalization of 
nanoparticles and flat substrates can be achieved by using molecular biology 
protocols (Tamerler et al., 2006a; Kacar et al., 2009a). 
Solid-binding peptides can also be fused to proteins (Dai et al., 2005) and other 
peptides (Slocik and Naik 2006), conjugated to functional small molecules or 
attached to quantum dots (Zin et al., 2005; Ma et al., 2007; Zin et al., 2007) to 
develop molecular building blocks or multifunctional molecular entities for various 
applications including efficient immobilization of enzymes, conjugation of 
nanoentities, nanoparticle synthesis with controlled size  (Kramer et al., 2004; 
Krauland et al., 2007; Kacar et al., 2009b; Park et al., 2009), selective 
immobilization of fluorescent proteins (Yokoo et al., 2010) and for direct assembly 
or  in situ synthesis of other functional inorganic nanostructures (Brown 2001; 
Pender et al., 2006; Sano et al., 2006; Slocik and Naik 2006). 
1.4.1.4 Fabrication of multifunctional micropatterned substrates using GEPI 
Protein microarrays are fabricated by spatial immobilization of proteins on desired 
inorganic surfaces through several lithography techniques including soft lithography, 
dip-pen lithography and photolithography (Xia and Whitesides 1998; Revzin et al., 
2001; Lee et al., 2002).  
Immobilization provides a physical support to the protein, making the reuse of the 
protein possible by separating the protein from solution easily (Bornscheuer 2003). 
The surface is generally functionalized by self-assembled monolayers (SAMs) of 
bifunctional molecules for the immobilization of biomolecules on glass or metal 
surfaces (Mrksich and Whitesides 1996; Ostuni et al., 1999). These bifunctional 
molecules have some limitations.  
Bifunctional molecular constructs including inorganic substrate binding capability 
and certain functionalities can be designed using genetic engineering techniques 
(Sarikaya et al., 2003). In a recent alternative technique solid binding peptides with 
strong binding affinity to inorganics are exploited for the immobilization of 
nanoparticles and biomolecules. Beside their high inorganic binding capability,  high 
substrate and biomolecular specificity of GEPIs is an advantage for protein 
immobilization. In the previous studies, functional proteins and nanoparticles were 
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immobilized on inorganic surface (Woodbury et al., 1998; Park et al., 2006; Kacar et 
al., 2009b; Yokoo et al., 2010) and SiO2, Ag and Au nanoparticles and protein-Cu2O 
nanostructures were sytnhesized by exploiting inorganic peptides (Brown et al., 
2000; Brott et al., 2001; Naik et al., 2002; Zin et al., 2005).  
Polydimethylsiloxane (PDMS) stamping is a common soft-litography technique for 
constructing protein patterns (Bernard et al., 2000; Yang and Chilkoti 2000; Inglis et 
al., 2001; Tan et al., 2002; Pla-Roca et al., 2007). The original master template is 
used for the fabrication of PDMS mold. Following coating with proteins, the mold 
contacts the substrate surface. Afterwards, the mold leaves a protein pattern on the 
surface (Figure 1.6). 
 
Figure 1.6 : Schematic illustration for PDMS patterning of proteins. The original 
master template is used for the fabrication of PDMS mold. Following 
the coating with the proteins, the mold contacts the surface of the 
substrate. Afterwards, the mold leaves a protein pattern on the surface 
(Truskett and Watts 2006). 
Gold nanoparticles, streptavidin functionalized quantum dots and functional proteins 
have been directly immobilized on gold surface by microcontact printing of gold 
binding peptides in previous studies (Zin et al., 2005; Park et al., 2006; Zin et al., 
2007). Kacar et al. (2009b) have demonstrated micropatterning of fluorescent 
quantum-dot nanocrystals and fluorescein, on quartz surface, immobilized through a 
quartz-binding peptide. 
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1.4.1.5 Attachment of nanoentities on the substrate 
In nanotechnological and biological material science and engineering applications 
controlled binding and assembly of proteins onto inorganic substrates is a key issue 
(Drexler 1994; Ryu and Nam 2000; Niemeyer 2001; Tamerler et al., 2010). 
With their structure, composition, size and surface related optical, magnetic and 
electronic properties, nanoparticles have importance in nanotechnology (Alivisatos 
1996; Hines and Guyot-Sionnest 1996; Lewin et al., 2000; Santra et al., 2001; Daniel 
and Astruc 2004). Gold and silver nanoparticles which have been used for labelling 
in immunoassay studies (Schultz et al., 2000; Nam et al., 2003) and in cytologic 
imaging (Loo et al., 2005; Lee et al., 2007), absorb and scatter light, and can be 
detected by optical microscopy (Wiley et al., 2006; Chen et al., 2007; Anker et al., 
2008). With the ability of converting minute changes in the refractive index into 
spectral shifts in the spectral data, gold and silver nanoparticles can be used for 
determining the binding of molecules on particles (Nath and Chilkoti 2002; Yonzon, 
et al., 2004).   
Zin et al have demonstrated utility of GEPIs in the controlled organization of gold 
nanoparticles on the surface. Three repeats of GBP-1 (Brown et al., 2000) gold-
binding protein (42 amino acids, [MHGKTQATSGTIQS]3) have been physically 
and chemically patterned by microcontact printing.  Obtained patterns functioned as 
templates for the direct the assembly of gold nanoparticles (Zin et al., 2005). 
1.4.1.6  Studies on the mechanism of molecular recognition of GEPIs 
The structural effect of originally selected Pt-, Au-, and Cu2O-binding peptides on 
their binding to inorganic surfaces have been studied in recent reports. All these 
inorganic binding peptides were selected from constraint peptide libraries (Choe et 
al., 2007; Seker et al., 2007; Hnilova et al., 2008). 
Hnilova et al have selected two gold-binding peptide (AuBP1 and AuBP2) sequences 
using a FliTrx random peptide display library. Following the synthesis of  cyclic, as 
displayed on the bacteria, and linear dodecapeptides, adsorption behavior of the 
peptides were analiyzed. After performing CD spectra and molecular dynamics 
analyses,  they have found that the cyclic AuBPs have mainly random coil structures, 
on the other hand the linear versions also have some degree of polyproline type II 
(PPII) rigid structures in addition to the random coil (Figure 1.7).  
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They have demostrated that the circular and linear forms of AuBP1 retained the 
molecular conformation and had similar adsorption behavior. On the contrary AuBP2 
have revealed different molecular structures in the circular and linear forms. 
Consequently the two peptides had different gold binding affinities (Hnilova et al., 
2008). 
 
Figure 1.7 : Predicted molecular structures of  the linear and cyclic version of 
AuBP1 (A) and AuBP2 (B). Ribbon and transparent surface models of 
the structures were overlapped. The percentage of PPII structure in 
linear AuBP2 is greater than that in linear AuBP1. RC: Random coil, 
PPII: polyproline type II structure (Hnilova et al., 2008). 
Choe et al have used a derivative of the DNA binding protein TraI mutated with a 
cuprous oxide binding peptide called CN225 to show the influence of sequence 
composition and conformation on the binding affinity. They have demonstrated that 
the presence of disulfide constrained loop is crutial for binding (Choe et al., 2007).  
Seker et al, have used circular and linear form of high-affinity seven amino acid Pt-
binding sequence and analyzed them for their a adsorption behavior on Pt thin films 
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by surface plasmon resonance spectroscopy and for their conformational properties 
by circular dichroism. They have concluded that circularization affects both the 
conformation and binding behavior  of the Pt-binding peptide (Seker et al., 2007).  
In the light of these data, it has been found that when the inorganic binding peptide 
retains its molecular conformation in both cyclic and linear forms, it also preserves 
similar adsorption behavior on the surfaces. However, when the molecular structure 
of the respective sequence in the linear forms differs from their cyclic, a decrease is 
observed in the solid-binding affinities (Tamerler et al., 2010). 
1.5 The Fluorescence Phenomenon 
Fluorescence, as the most sensitive spectroscopic technique available, is a 
phenomenon that comprises two stages, excitation and emission. A fluorophore, the 
fluorescent chromophore, absorbs a photon, for a few nanoseconds remains in this 
state called as excited state and then emits a lower energy photon. Hence the 
intensity of a fluorescent molecule depends upon both the absorption of light and the 
emission of photon from the excited fluorescent chromophore (Johnson 2005).  
Herschel has reported a visible emission from a natural source, an aqueus quinine 
solution in 1845 (Herschel 1845). In 1852 Stokes reported that this fact was because 
of the absorbtion and then emission of light by the first defined small molecule 
fluorophore quinine. Stokes called this process as fluorescence (Lavis and Raines 
2008; Stokes 1852). After this progress the fluorometer was developed. The intrinsic 
fluorescence of quinine is responsible for developing of the first spectrofluorometers 
which were needed to monitor antimalarial drugs, including quinine during World 
War II (Lakowicz 2006). Today numerous other fluorophores are available including 
genetically encoded fluorophore GFP.  
In the Figure 1.8, Jablonski Diagram illustrates the process of molecular 
fluorescence. S0 is the singlet ground state which is the nonexcited state of a 
molecule, S1 and S2 are first and second singlet excited states and T1 is the triplet 
state. The fluorophore molecule in a S0 state absorbs light energy and this promotes 
the fluorophore from S0 to S1 or S2. The relaxation of excitated state can occur with 
radiative way, by releasing energy in the form of light (fluorescence) or with 
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nonradiative way including bond rotation or vibration, molecular collision and 
photoinduced electron transfer (PeT) (Lavis and Raines 2008; Lakowicz 2006). 
 
Figure 1.8 : Jablonski Diagram (Lavis and Raines 2008). 
In a less common way, excited state can transit to T1 by intersystem crossing. The 
decay of the excited state can occur with radiative way, by photon emission 
(phosphorescence) or with nonradiative way. In the radiative transition process, 
energy of the emission is lower than the absorbed energy, due to loss of energy 
during the excited state. During fluorescence process emitted light is at a lower 
energy and has longer wavelength (Figure 1.9). This is named as the Stokes shift 
(Lavis and Raines 2008; Lakowicz 2006). Fluorophores have different Stokes shifts. 
Large shifts make it possible to separate  the exciting alight easily (Lichtman and 
Conchello 2005). 
Emission spectrum is generally used for presenting the fluorescence spectral data. 
This spectrum can be determined using a fluorescence measuring device after 
exciting the fluorophore at a convenient wavelength (Lichtman and Conchello 2005; 
Lakowicz 2006). Obtained spectrum is a plot of the fluorescence intensity versus 
wavelength or wavenumber. In the cases of wavelength and wavenumber nanometers 
and cm-1 units are used respectively (Lakowicz 2006).  
Quantitavely reproducible signals come from the fluorescently labeled samples 
containing less than even 1 nM concentration of fluorescent chromophore. This 
concentration is much lower than those required for other spectral techniques. The 
signal can be analyzed using fluorescence intensity, lifetime, wavelength and 
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polarization or anisotropy to have knowledge of a structure, interaction, mechanism 
or process (Heuck et al., 2000; Ramachandran et al., 2004; Woolhead et al., 2004). 
 
Figure 1.9 : Absoption and emission spectra showing Stokes shift (Lavis and 
Raines 2008). 
In addition, because of its nondestructiveness, signal change in the fluorescent 
molecule can be analized as a function of time to reveal its kinetics propeties 
(Johnson 2005). 
1.6 Fluorescence Detection Technology 
Fluorescent detection technology is used by many disciplines including biological 
science. With recent progresses, extensive use of highly sensitive fluorescence 
detection techniques have become more eligible. These techniques do not reqauire 
use of any radioactive tracers for the measurement of most biological measurements 
(Lakowicz  2006).  
There are several fluorescent detection techniques including measurement of 
intensity, fluorescent polarization anisotropies, Förster resonence energy transfer 
(FRET) and fluorescence lifetimes available for the investigation of biomolecules or 
biomolecular processes.Fluorescence intensity which can be measured using 
fluorescence microscopy is generally used for qualitative data. On the other hand, 
ratiometric methods which are based on the measurement of at least two parameters 
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are used for quantitative identification (Deniz et al., 2001; Tinnefeld and Sauer 2005; 
Li et al., 2008; Walla 2009). 
Fluorescence polarization assay which gives a quantitative data for binding affinities 
is based on the measurement and comparison of the horizontal and vertical 
components of the fluorescence polarization. Using fluorescently labeled 
components, this assay can be exploited for receptor-ligand binding, proteolysis, 
protein-DNA interactions and membrane fluidity (Kim et al., 2006; LiCata and 
Wowor 2008; Xi and Deprez 2010).  
FRET technique describes nonradiative energy transfer between two fluorescence 
chromophores. Small donor-acceptor distances are needed for effective energy 
transfer in this technique. If the acceptor and door fluorescent molecules are in close 
vicinity, energy transfer is observed between excited donor and the acceptor through 
dipole-dipole coupling. Many investigations including receptor-ligand binding 
interactions, conformational transitions of biomolecules, lipid membrane 
transformation can be performed using FRET technique. It also provides a nm scale 
molecular ruler to measure the distance between fluorescently labeled biomolecules. 
Another fluorescent technique is the measurement of fluorescence kinetics which 
change during biomolecular processes. However, it is hard to predict an incident that 
gives fluorescent kinetic data based on biomolecular changes (Jares-Erijman and 
Jovin 2003; Piston and Kremers 2007; Walla 2009). 
Fluorescence Recovery after photobleaching (FRAP) based on the photochemical 
bleaching of fluorescence molecules in the sample. After the bleaching pulse has 
been applied, the fluorescence recovery kinetics are observed. This technique is used 
to figure out molecular diffusion of labeled agents in the sample for the membrane 
structure and cytoskeletal dynamics studies. Fluorescence recovery data gives 
knowledge about mobility of the fluorescence molecule (Trugnan et al. 2004; 
Sprague and McNally 2005; Walla 2009). 
1.6.1 Fluorescence microscopy 
In the absorption techniques, samples are stained with dyes that absorb light. In this 
case, the amount of light absorbed by the small parts of the samples has a very small 
difference from the background. One can see only parts of the sample that have 
fluorescence by filtering the exciting light without blocking the emitted light. At this 
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point, Stokes shift becomes one of the most important characteristics of fluorescence. 
Using fluorescence techniques it is possible to visualise even single molecules 
(Lichtman and Conchello 2005; Gell et al., 2010). 
In fluorescence microscope system, the sample is illuminated with specific 
wavelength and the returned light is filtered to see only longer wavelength by 
seperating the emitted light from the excitation light. In modern fluorescence 
microscopy generally epi-fluorescence illumination technique which exploites 
incident-light (i.e., episcopic) is used. In epi-fluorescence illumination approach, the 
objective of the microscope serves as a conderser in addition to its imaging and 
magnifying role. The numerical aperture (NA) of the objective is an important 
parameter which has critical effects on the resolving power and light efficiency of the 
objective. An objective with a high NA is preferable for an ideal fluorescence 
microscope (Stanley 2003; Lichtman and Conchello 2005). 
Development of the wide range of fluorophore molecules  has multiplied the usage of 
fluorescent microscope as an essential tool. Although in both system, samples are 
exicitated equivalently, epi-fluorescence microscopy has advanteges over diascopic 
fluorescence microscopy. In diascopic fluorescence system exciting light comes 
through the condenser after passing through an excitation filter and the objective 
collects the fluorescence emission (Lichtman and Conchello 2005). In this approach 
brightfield and darkfield condensers are used. With brightfield condenser the 
maximum intensity is limited by the optical filters capacity. Darkfield condenser of 
the diascopic fluorescence system prevents entering most of the excitation light to 
objective. In this way the requirement of the optical filters is reduced, but at same 
time, the objective requires a smaller NA and the final efficiency of the illumination 
and the brightness are reduced (Reichman 2007). 
In epi-fluorescence approach emitted fluorescence passes through a barrier and in 
this mode of fluorescence microscopy only the small amount of exciting light needs 
to be suppressed by barrier filter (also called emission filter or emitter). This filter 
passes the longer wavelengths and blocks the remaining shorter wavelength 
(excitation). To prevent the overlapping the exciting light passed by excitation filter 
and the fluorescence, a kind of filter, dichroic mirror splitter is used (Lichtman and 
Conchello 2005; Reichman 2007). 
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The dicroic mirror reflects excitating light (short wavelength) comes from the light 
source and passes the emitted fluorescence (longer wavelength). The primary 
filtering component of the epi-fluorescence microscopy is a unit composed of three 
filters which are held in a fluorescence filter cube (small block shaped filter holders). 
This fluorescence filter cube is a set of excitation filter, barrier filter and the dichroic 
beamsplitter. The cubes can be fitted into a circular carousels or linear blocks 
carrying seperate cubes thar can be moved into desired positions (Lichtman and 
Conchello 2005; Reichman 2007). Other advanced fluorescence based techniques 
such as confocal, multiphoton, stimulated emission depletion (STED), structured 
illumination, total internal reflection fluorescence (TIRF), FLIM, FRET, 
fluorescence recovery after photobleaching (FRAP) and fluorescence correlation 
spectroscopy (FCS) are also available to study fluorescent molecules (Gurunathan 
and Levitus 2008; Masi et al., 2010; Wessels et al., 2010). 
1.6.2 Spectrofluorophotometer 
The wavelengths affect the efficiency of monochromotors and detector tubes in 
spectrofluorometers. In addition to this and the other instrumental factors like the 
polarization or anisotropy of the emitted light, the optical properties of the specimens 
like optical densitiy and turbidity effect the excitation  and emission spectra. The 
wavelength distribution of an emission measured at a certain excitation wavelength 
represents an emission spectrum (Hart and JiJi 2002; Lakowicz 2006). In an 
excitation spectrum different wavelength of excitation light is scanned  at a constant 
emission wavelength. The spectral data can be given on a wavelength scale 
(nanometer) or wavenumber scale (cm-1). The units of wavelengths  and 
wavenumbers can be interconverted. 
The spectrofluorometer in the Figure 1.10 has a xenon lamp that has high intensity at 
all wavelenghts as a exciting light source. For the selection of the excitation and 
emission wavelengths the instrument has both excitation and emission 
monochromators. There are two  concave gratings in this spectrofluorometer as 
shown in the figure. Wavelengths different from the desired one is decreased by 
these gratings. It is possible to scan wavelengths automatically using the 
monochromators. After the detection of the fluorescence by photomultiplier tubes 
(PMT) the quantified data is commonly presented in graphical form (Lakowicz 2006; 
Sharma and Schulman 1999). 
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Figure 1.10 : Schematic diagram of a spectrofluorometer (Lakowicz 2006). 
The sample holder is shown in the middle of the optical module containing different 
components such as shutters, filter holders, beam splitter, polarizer and reference 
cell. Shutters eliminate the exciting light or close the emission channel (Lakowicz 
2006; Sharma and Schulman 1999).  
The beam splitter in the excitation light path reflects some part of the excitation light 
to reference cell containing a reference fluorophore for correction of the effects of 
instrumental factors and optical properties of the sample. Polarizers provided to 
select for particular polarized components of the emission or excitation are usually 
removable components of the spectrofluorometer. In addition to other components in 
the figure, there is an additional optical path which allows measurement of 
fluorescence anisotrophy. In the present design of the instrument there is generally 
no need to use this kind of additional path for fluorescence anisotrophy 
measurement. Fluorescence microplate readers provide measurement of numerous 
samples rapidly using multiwell plates instead of the individual cuvettes . They are 
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generally used for intensity measurements. There are some differences between the 
spectrofluorometers designed for single sample and for multisample in respect to 
optics used in the design. Multiwell plates are placed horizontally. The main 
difference is use of the mirror with a hole which transmits the excitation. 
1.7 An Introduction to Fluorescent Probes 
Fluorescent probes that combine fluorescent properties and molecular recognition 
have been used to visualize biological events at many levels from molecules to an 
organism (Finney 2006; Giepmans et al., 2006). There are thousands of fluorescent 
probes available. Properties of the probs and the fluorophores are considered for 
designing. Fluorescence instruments need the information on spectral properties of 
the fluorophores which can be divided into two classes, intrinsic and extrinsic. While 
intrinsic fluorophores including the aromatic amino acids, NADH, flavins and 
chlorophyl occur naturally, extrinsic fluorophores are added to the sample to provide 
fluorescence or change the spectral properties (Lakowicz 2006). It is important to 
choose a suitable fluorescence probe to visualize, describe and analyse a biochemical 
or biological process (Figure 1.11). 
 
Figure 1.11 : Size comparison of green and red qdots, FITC, fluorescein 
isothiocyanate; GFP; CdSe/ZnS qdot; qrod, rod-shaped qdot, 
streptavidin (SAV), maltose binding protein (MBP), and 
immunoglobulin G, IgG (Michalet et al., 2005). 
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1.7.1 Small organic dyes for fluorescence detection 
Small organic dye molecules, which are commercially available from many sources 
(Haugland 2002), are used for covalent labeling of macromolecules. They have been 
implemented for optimization of wavelength range, brightness, photostability and 
reduction in quenching. However, due to their unspecificity for any particular 
protein, antibodies are used for many applications. 
Small organic dyes are attached to the protein of interest with antibodies. On the 
other hand, targeting of the antibody in the intracellular compartments requires 
fixation and permeabilization of the cells (Giepmans et al., 2006). 
1.7.2 Quantum dots as fluorescence probe 
Quantum dots (QDs) have sharp and discrete fluorescence wavelengths depending on 
their size. These inorganic nanocrystals have 10 to 100 times higher extinction 
coefficient than those of small organic dyes and fluorescent proteins. QDs those have 
good quantum yields contain a CdSe or CdTe core and ZnS shell (Giepmans et al., 
2006). It is a challenging step the development of coatings for QDs that make them 
water soluble, prevent quenching in water and make it possible to conjugate to 
protein targeting molecules (Jaiswal and Simon 2004; Alivisatos et al., 2005; Gao et 
al., 2005; Michalet et al., 2005). 
1.7.3 Fluorescent protein paintbox 
Antenna pigment proteins, phycobiliproteins introduced in 1982 as the first 
fluorescent proteins used in cell biology, were exracted from cyanobacteria. 
Photosynthetic pigment protein (antenna) complex containing organisms such as red 
algae and cyanobacteria has the significant range of spectral variation in their 
antenna pigments (Oi et al., 1982; Glazer 1989).  Each phycobiliprotein 
macromolecule contains multiple chromophores encapsulated in a matrix. This 
provides minimized quenching and higher brightness to the macromolecules than 
small organic dyes. With its size of 200 kD, applications of phycobiliprotein has a 
diffusion limitation. Labeled proteins or probes can not diffuse properly into cell 
compartments, tissues and other  region of  interest. Therefore, they have been used 
for surface labelling in flow cytometry and enzyme-linked immunosorbent assay, 
ELISA  (Giepmans et al., 2006; Waggoner 2006). 
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Phytochromes containing nonfluorescent chromophores are light sensitive proteins 
present in photosynthetic organisms. Some phytochromes spontaneously binds 
phycoerythrobilin and become fluorescent. Murphy et al designated these 
phytochromes as phytofluors (Murphy and Lagarias 1997). Apophytochrome can be 
expressed recombinantly (Gambetta and Lagarias 2001). A recent report has shown 
that a tyrosine to histidine mutation made the phytochrome fluorescent (Fischer and 
Lagarias 2004). 
1.7.3.1 The structure and function of green fluorescent protein 
Green Fluorescent Protein (GFP) is a commonly used biological marker in molecular 
biology, medicine and cell biology. Its chromophore structure is formed in an 
autocatalytic cyclization process. Because of its stability and the fact that its 
chromophore formation does not require a cofactor GFP can be use in living systems 
(Zimmer 2002).  
GFP and Aequorin protein containing coelenterazine are involved in the 
bioluminescence in Aequorea (Figure 1.12). Following the binding, three calcium 
ions, aequorin oxidizes the coelenterazine molecule. The resulting protein complex 
emits blue light. Instead of emitting blue light, Aequorea transfer this energy to GFP 
(Zimmer 2002). 
 
Figure 1.12 : Bioluminescence mechanism in Aequorea victoria (Adapted from 
Zimmer  2002). 
Studies with molecular basis for the fluorescence of Aeuqorea were started by 
Shimomura (1962). After denaturation and digestion of GFP, he isolated a peptide 
fragment containing the chromophore and he proposed the structure of GFP 
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chromophore. Following the first cloning Aequorea GFP by Pracher in 1992, GFP 
was expressed in bacteria by Chalfie et al in 1994 (Shimomura et al., 1962; Prasher 
et al., 1992; Chalfie et al., 1994).     
Jellyfish Aequorea victoria GFP is a 238-amino acid long polypeptide with a unique, 
rigid β-sheet barrel structure (Figure 1.13). A variety of variants of GFP with 
improved fluorescent roperties, have been produced recently (Chudakov et al., 2005; 
Miyawaki et al., 2005; Day and Davidson 2009). 
 
Figure 1.13 : Three-dimensional structure (β-can) of wild-type green fluorescent 
protein (GFP) and approximate dimensions (Day and Davidson 
2009). 
Spectral variants of EGFP emitting blue (EBFP), cyan (ECFP) and yellow (EYFP) 
fluorescence were also created by several mutations (Schmid and Neumeier 2005). 
GFP variants became commonly used tools in molecular and cellular biology as 
biological markers due to their robust biological and fluorescence properties 
(Lippincott-Schwartz and Patterson 2003). A GFPuv variant carrying the cycle 3 
mutations has an emission maximum at 509 nm and an excitation maximum at 395 
nm was reported by Crameri et al (Crameri et al., 1996).  
In addition to Aequorea GFP, cloning of a red fluorescent protein DsRed from 
Discosoma sp. has made it possible to extend the range of fluorescence further into 
the red part of the spectrum (Du et al., 2006). After creating the first monomeric red 
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fluorescent protein mRFP1(Campbell et al., 2002), mFruits fluorescent proteins were 
introduced by Tsien group (Shaner et al., 2004; Wang et al., 2004). 
Information about detection of the promoter activity, protein localization, motility 
and interactions with other proteins in living cells or various cellular parameters in 
living animals can be obtained by exploiting fluorescent protein variants (Hoffman 
2002; Chudakov et al., 2005; Wiedenmann et al., 2009). 
1.7.4 Fluorescent tagging for labeling 
Immunolabeling and genetic tagging are general techniques for tagging of proteins. 
Using labelling techniques researchers can combine fluorescent techniques and 
biomolecules. For the detection of endogenous proteins the sample is labeled with a 
primary antibody and then amplified with a secondary antibody conjugated to a small 
organic dye or a QD. In an alternative way, primary antibody can be conjugated 
directly to fluorescent molecule. The specificity of the primary antibodies is very 
important for the accuracy of protein recognition.  
In some applications there are some disadvantages and restrictions for 
immunolabeling technique. Fluorescence molecule-targeting complexes can have a 
size over 200kD and might prevent the recognition of multiprotein in protein 
complexes. Immunolabelling can be applied for permeabilized cells or extracellular 
or endocytosed proteins. In the other approach, the protein of interest is genetically 
tagged with  fluorescent proteins (Giepmans et al., 2006).  
Covalent fusion of the fluorescence molecule is very advantageous for targeting of 
the sample. In addition to these techniques, some hybrid systems in which small 
molecules are covalently targeted to specified proteins of living cells, via 
spontaneous attachment or enzymatic ligation are used.  
The most studied one is the tetracysteine-biarsenical system. Fusion proteins carrying 
the tetracysteine tag can be labeled covalently using this system. Tetracysteine tag  
specifically binds to biarsenical compaunds such as a fluorescein derivative green 
F1AsH and a resorufin derivative red dye ReAsH. Inspite of their relatively small 
size, biarsenical fluorophores can couse unspecific binding (Griffin et al., 1998; 
Gronemeyer et al., 2005; Giepmans et al., 2006). 
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Developments in fluorescent probs and imaging approaches make imaging brighter, 
more stable and more informative, additionaly provide higher resolution and greater 
tissue penetration. It is important to understand biological systems and to get 
knowledge about biological events from molecule to organism level in life science. 
Fluorescent imaging make it possible to measure biological events such as gene 
expression, protein localization, activation and interaction (Du et al., 2006). 
1.8 Quenching of Fluorescence 
Fluorescence life time and quantum yield are informative characteristicts for a 
fluorophore molecule. Fluorescence lifetime determines the information available 
from emission of the fluorophore. The fluorophore interacts with or diffuse in the 
environment in time. The fluorescence quantum yield is measured as ratio of number 
of the emitted photons to the number of absorbed photons. Higher quantum yield 
increases the intensity (Lakowicz 2006; Lichtman and Conchello 2005).  
In many dyes such as NBD (7-nitro-benz-2-oxa-1,3-diazole) the intensity primarily 
depends on the alterations in the efficiency of photon emission (Crowley et al., 
1993). On the other hand, in other dyes like fluorescein, the intensity changes result 
from changes in the absorbance that depends on the pH, environment or other effects 
(Mercola et al., 1972; Adkins et al., 1983).  
Quenching is the decrease in the intensity of the fluorescence by a variety of 
mechanisms. Deactivation of the excited state fluorophore upon contact with the 
quencher molecule is called as collisional quenching. Molecules such as oxygen, 
halogens, amines, and electron deficient molecules can act as collisional quenchers. 
Formation of nonfluorescent complex by the fluorophore and the quencher molecule 
is another quenching process. Non molecular mechanisms can also cause quenching 
(Lakowicz 2006). 
The location of probes on macromolecules can be determined by use of the 
fluorophore and quencher pairs (Lakowicz 2006). 
1.8.1 Quenchig by metallic nanoparticles 
In the quenching mechanism by metallic nanoparticles the distance is larger than the 
mechanism for molecular quenchers and FRET (Algar et al., 2009). Dulkeith et al. 
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have shown that fluorescent dyes quenched at distance as large as 16 nm (Dulkeith et 
al., 2002; Dulkeith et al., 2005). In addition, it has been found that QDs quenched at 
21 nm distance (Pons et al., 2007).  
It has been suggested that the efficiency of quenching by gold nanoparticles depends 
on the size and shape of the nanoparticle, distance from the fluorophore, spectral 
overlap and dipole orientation (Dulkeith et al., 2002; Dulkeith et al., 2005; Algar et 
al., 2009). On the other hand, the exact mechanism for the quenching has not been 
exhibited yet (Algar et al., 2009). Pons et al (2007) have found that gold NPs provide 
the additional nonradiative decay pathway like energy transfer for quenching of QDs. 
However, Dulkeith et al (2005) have demonstrated that changes in the radiative rate 
of the fluorophore induces more significant quenching than energy transfer. It has 
been also shown that surface bound dye have a 10 fold decrerease in radiative rate 
while there is a 10 fold increase in non radiative rates (Dulkeith et al., 2002). This 
study also suggested that 5-10 nm diameter gold NPs are optimal quenchers (Algar et 
al., 2009). Gold nanoparticles mostly used as quencher for molecular beacons 
exploiting fluorophores or QDs in nucleic acid analysis (Dubertret et al., 2001; Cady 
et al., 2007). 
1.9 Biomineralization and Proteins 
Biomineralization is the process by which organisms produce minerals with 
controlled hierarchical structures across the dimensional scales from the nanometer 
and up resulting superior properties compared to synthetic materials with similar 
phase compositions (Lowenstam 1981; Addadi and Weiner 1985).  
There is a major interdisciplinary interest on biomineralization among geologists, 
biologists, materials scientists and bioengineers in both the fundamental 
understanding and mimicking to develop hybrid materials with controlled structures 
and functions with technological and medical interests. Different types of minerals, 
ranging from silicates, carbonates, phosphates, metals and metal oxides, have been 
identified in a variety of species (Lowenstam 1981; Addadi and Weiner 1985).  
Biological hard tissues are dynamic, complex, self healing and multifunctional and 
have a highly controlled architectural organization from nanoscales to macroscales, 
often in a hierarchical manner (Sarikaya et al., 2003; Tamerler et al., 2010). 
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In the formation of biogenic minerals in living organisms, proteins have a key role 
for the regulation the mineralization process. Proteins participate the 
biomineralization and influence nucleation, crystallography, polymorphism and 
morphology of biogenic inorganics (Addadi and Weiner 1985; Sarikaya 1995; Mann 
1996). Biomimetic approach can be applied to utilize these proteins in designing and 
engineering of functional materials. Proteins can also be obtained by extracting from 
hard tissues. Following the isolation, purification and cloning steps (Cariolou and 
Morse 1988; Glimcher and Nimni 1992; Paine and Snead 1997; Liou et al., 2000) 
such biomineralizing peptides can be used in the synthesis of certain inorganics 
(Berman et al., 1988; Belcher et al., 1996; Cha et al., 1999). However, hard tissues 
usually contains many proteins with a complex spatial and temporal distribution that 
makes their extraction and purification from hard tissues difficult. As a more 
practical approach, the combinatorial selection of peptides through display 
techniques is efficient for selection of peptides that specifically bind to inorganic 
surfaces (Brown et al., 2000; Sarikaya et al., 2003). 
1.9.1 Combinatorially selected hydroxyapatite binding peptides 
Hydroxyapatite (HA), being the principal inorganic component of the hard tissues in 
mammalian organisms, such as bone and teeth, has been one of the most extensively 
studied biominerals. HA is widely utilized in hard tissue repair, replacement and 
implant surface coating. In addition to these fields, HA has also been reported as a 
potential gene/drug and cell delivery agent (Dash and Cudworth 1998; Liu et al., 
2005; Tan et al., 2007; Ma et al., 2008; Braux et al., 2009) and regulator of cell 
bioactivity (Oh et al., 2005; Kasaj et al., 2008).  
Phage-display selected hydroxyapatite-binding peptides (HABP1 and HABP2) have 
been reported by Gungormus et al. Binding and molecular structural properties of 
HABPs have been provided (Gungormus et al., 2008). 
Among the selected peptides, a high affinity HA binding heptapeptide, with the 
amino acid sequence of CMLPHHGAC, was also demonstrated to have mineral-
forming capabilities. It has been observed that the addition of HABP1 into the 
reaction, slowed the rate of initial mineralization and formed the larger particles 
compered to weak binder HABP2 (CNPGFAQAC) and control no-peptide sample 
(Figure 1.14). On the other hand, the rate of transformation of the amorphous phase 
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to the crystalline phase has been increased upon addition of HABP1 (Gungormus et 
al., 2008). 
 
Figure 1.14 : The morphology of the minerals formed in the presence of a,b) no 
binder, c,d) weak binder  HABP2 and e,f) strong binder HABP1 at 
96 h (Gungormus et al., 2008). 
A  twenty-seven residue peptide  containining a heptapeptide (MLPHHGA) at the C-
terminal  has been designed that directs the formation of hydroxyapatite. It has been 
reported that the peptide folded and assembled to form a hydrogel network and the 
peptide gels were capable of directing the formation of hydroxapatite (Gungormus et 
al., 2010). 
1.9.2 Labelling HA formation 
Tracking of HA formation, via efficient labeling is very important in biomedical 
application, e.g., gene/drug delivery, bone and teeth formation/remodeling, and in 
nano-technological implementations, e.g., nano-particle composites. HA can be 
labelled via several ways. Alizarin red S (Lipman 1935) and von Kossa staining 
(Meloan 1985) are the golden standards for in vitro staining of HA. However, both of 
these methods are only applicable in the ex vivo labeling of HA. 
The methods for potential applications of HA labeling include synthesizing HA 
particles doped with fluorescent ions(de Araujo et al., 2007; Yang et al., 2008), 
synthesizing HA-quantum dot composites (Guo et al., 2008; Hsieh et al., 2009) or 
modifying the surface of the HA using chemical coupling agents such as 
bisphosphonates (Zaheer et al., 2001; Zhang et al., 2008). On the other hand, existing 
methods have complex chemistries required for labeling and the dopants or the 
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composites can couse a toxicity. For instance, although quantum dots have great  
potential in many research and diagnostic applications, they are still considered toxic 
when they are used in studies involving living systems (Alivisatos et al., 2005; 
Hardman 2006). Moreover, bisphosphonates, used as a chemical linker, because of 
their high affinity to hard tissues, have the risk for disrupting bone turnover due to 
their inhibitory effects on osteoclasts (Boonekamp et al., 1986; Weinstein et al., 
2009). 
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2.  MATERIALS AND METHODS 
2.1 Cloning Construction, Expression and Analyses of Histidine Tagged GFPuv 
Fusion Proteins 
2.1.1 Oligonucleotide primers for GFPuv-HABP constructs 
Primers were designed for constructing original phage selected constraint HABP1 
and HABP2 fusion proteins, GFPuv-HABP1 (C-MLPHHGA-C), GFPuv-HABP2 (C-
NPGFAQA-C), and linear HABP1 fusion GFPuv-HABP1Met (MLPHHGA), linear 
reverse HABP1 fusion GFPuv-HABP1Ala (AGHHPLM) proteins and control 
GFPuv protein encoding expression vectors (Table 2.1). 
Table 2.1: Oligonucleotide primers used in PCR reactions for GFPuv, GFPuv-
HABP1, GFPuv-HABP2, GFPuv-HABP1Met, GFPuv-HABP1Ala 
constructs. 
Primer 
Name 
Sequence 
HAP1 5’-CGGGCATGCTATGAGTAAAGGAGAAGAACTT-3’ 
HAP2 5’-GCCAAGCTTTTATTTGTAGAGCTCATCCATGCC-3’ 
HAP3 5’-GCCAAGCTTTTAACAAGCACCATGATGAGGTAACAT GCAACCTCCACCCGATTTGTAGAGCTCATCCATGCC-3’ 
HAP4 5’-GCCAAGCTTTTAACAAGCACCATGATGAGG-3’ 
HAP5 5’-GCCAAGCTTTTAACAAGCCTGAGCAAAACCAGGATT GCAACCTCCACCCGATTTGTAGAGCTCATCCATGCC-3’ 
HAP6 5’-GCCAAGCTTTTAACAAGCCTGAGCAAAACC-3’ 
HAP7 5’-GCCAAGCTTTTAAGCACCATGATGAGGTAACATACC 
TCCACCCGATTTGTAGAGCTCATCCATGCC-3’ 
HAP8 5’-GCCAAGCTTTTAAGCACCATGATGAGGTAA-3’ 
HAP9 5’-GCCAAGCTTTTACATTAAAGGATGATGACCAGCACC TCCACCAGATTTGTAGAGCTCATCCATGCC-3’ 
HAP10 5’-GCCAAGCTTTTACATTAAAGGATGATGACC-3’ 
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2.1.2 Polymerase chain reaction for GFPuv-HABP DNA fragments 
The vector pGFPuv (Figure 2.1) was obtained from Clontech (Takara Bio Inc. USA) 
and used as a template in all polymerase chain reactions (PCR). The PCR 
experiments were performed using a high fidelity enzyme, pfu DNA polymerase 
(Fermentas International INC., Ontario, Canada). 
GFPuv encoding sequence was amplified using the forward HAP1 and the reverse 
HAP2 primers containing extra residues including a PaeI or HindIII site at their 5’ 
ends, respectively. The DNA fragment encoding GFPuv-fused  HABP1 (GFPuv-
HABP1) was obtained in a two PCR reactions.  
 
Figure 2.1 : pGFPuv vector map (Url-1). 
The first PCR reaction was kept in 15 cycle and performed using the forward primer 
HAP1 and the reverse primer HAP3 bearing the strong hydroxyapatite binding 
peptide (HABP1) coding sequence with HindIII cleavage site (Table 2.2). 
Table 2.2: First step PCR conditions for GFPuv-HABP constructs. 
Temperature Time Cycle 
95 oC 3 min 1 
95 oC 1 min 
50 oC 1 min 
72 oC 4 min 
 
15 
72 oC 10 min 1 
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The second PCR reaction was kept in 30 cycle and performed by using the forward 
primer HAP1 and the reverse primer HAP4 and the first PCR product as a template 
(Table 2.3). Using the same PCR strategy described above, the DNA fragment 
encoding GFPuv fused HABP2 (GFPuv-HABP2) was obtained by using the forward 
primer HAP1 and the reverse primer HAP5 with the control peptide (HABP2) coding 
sequence with HindIII cleavage site in the first PCR reaction and the reverse primer 
HAP6 in the second PCR reaction. Linear and reverse linear HABP1 constructs, 
GFPuv-HABP1Met and GFPuv-HABP1Ala, were also obtained through the same 
strategy above. HAP1 and HAP7 were used in the first, HAP1 and HAP8 were used 
in the second PCR reaction for GFPuv-HABP1Met. HAP1 and HAP9 was used in 
the first, HAP1 and HAP10 were used in the second PCR reaction for GFPuv-
HABP1Ala. 
Table 2.3: Second step PCR conditions for GFPuv-HABP constructs. 
Temperature Time Cycle 
95 oC 3 min 1 
95 oC 1 min 
55 oC 1 min 
72 oC 2.5 min 
 
30 
72 oC 10 min 1 
2.1.3 Agarose gel electrophoresis of PCR products 
1% agarose gel was prepared using 1XTAE (40 mM Tris-base, 20 mM Glacial acetic 
acid, 1 mM EDTA, pH: 7.6) buffer for analyzing the PCR product.  
Samples and the DNA marker (Appendix A1) X174 DNA/HinfI, Marker 10 
(Fermentas) were pipetted into the gel. After gel electrophoresis, EtBr stained 
samples were visualized by UV trans-illuminator. Following excising DNA fragment 
from the agarose gel with a scalpel MinElute kit (Qiagen) was used for the gel 
extraction.  
2.1.4 Cloning PCR products into PJET cloning vector 
Extracted DNA fragments were cloned into 1.2/Blunt Cloning Vector pJET (Figure 
2.2). Blunt-ended PCR products generated with the pfu DNA polymerase were 
 36 
ligated directly into the cloning vector using CloneJET PCR cloning kit (Fermentas). 
The reaction set up is given in Table 2.4. 
 
Figure 2.2 : pJET1/blunt vector map (Url-2). 
The ligation mixture was incubated at room temperature for 15 min. The pJET 
ligation mixture was used for bacterial transformation. 
Table 2.4: Components of the  pJET ligation reaction. 
Component  Volume 
2X Reaction Buffer 10 µL 
PCR product 1 µL 
pJET vector 1 µL 
Water, nuclease-free 7 µL 
T4 DNA Ligase 1 µL 
Total  20 µL 
2.1.4.1 Preparation of electrocompetent E. coli TOP10 
pJET plasmid clonings were carried out in E.coli Top10F’ with the following 
genotype [lacIq Tn10(Tetr)], mcrA _(mrrhsdRMS-crBC), f80lacZ_M15 _lacX74, 
deoR,recA1, araD139_(ara-leu)7697, galU, galK,rpsL (Strr), endA1, nupG . After 
streaking out the glycerol stock of E.coli Top10F’ (Invitrogen) cells onto LB-agar 
medium (10g/L Bacto-Tryptone, 5g/L Bacto-Yeast Extract, 10g/L NaCl, 15g/L agar 
pH: 7) plate, the plate was grown over night. A single colony was selected for the 
starter culture. 10 mL starter culture was grown overnight in 2XYT broth at 37°C. 
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Over night culture was inoculated into 500 ml broth containing 20 µg/ml tetracycline 
with a 1/100 dilution rate and placed into 37°C shaker until OD600 reached 0.6. After 
incubation, E.coli Top10F culture was removed and placed on ice for 30 min. Cells 
were centrifuged  at 4000 rpm for 15 minutes. Then, supernatant was removed and 
pellet was gently resuspended in 40 mL of cold dH2O and centrifuged at 4000 rpm 
for 15 min. The supernatant was removed again and the pellet was resuspended in 20 
ml of cold dH2O. After the centrifugation, the supernatant was discarded and cells 
were gently resuspended in 1 mL of ice cold 10 % glycerol. 50 µL aliquots of cells 
were prepared in 1.5 mL eppendorf tubes and frozen in liquid N2, and stored at -80 
°C.  
2.1.4.2 Transformation of pJET plasmids into E. coli TOP 10 
Electrocompotent E.coli top 10 cells were thawed on ice. 3 µL of the pJET  ligation 
mixture for each sample was added to the  tube containing competent cells. This 
mixture was transferred into the Gene-Pulser electroporator tube (Bio-Rad), which 
was placed into the MicroPulser electroporator (Figure 2.3) and treated at 1800V for 
2-3 seconds. The reaction mixture was transferred gently to a 2 mL eppendorf tube 
containing 300 mL 2XYT and incubated at 37 °C for 1 h on a shaker. Then, 100 µL 
of culture was spread on LB plate containing 100 µg/mL ampicillin. The LB plate 
was incubated at 37°C over night.  
 
Figure 2.3 : MicroPulser electroporator (Bio-Rad). 
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2.1.5 Colony screening  for pJET constructs 
pJET cloning vector contains the gene for a restriction endonuclease which is lethal 
for the E.coli strains used for cloning. Ligation of a PCR product into the cloning site 
disrupts this lethal gene. Thus, only cells with recombinant plasmids are able to 
propagate (Url-2). All the vectors in this study contained ampicillin gene as a 
selection marker, therefore media and agar plates with ampicillin were used to grow 
and select the transformed colonies. With the help of positive selection system of 
pJET, only the recombinant colonies are able to grow on the plate. Colonies were 
analysed for the presence and orientation of the DNA inserts using the restriction 
analysis.  
2.1.5.1 Plasmid isolation 
Colonies were selected and inoculated into LB broth (10g/L Bacto-Tryptone, 5g/L 
Bacto-Yeast Extract, 10g/L NaCl, pH: 7)  with 100 µg/mL ampicillin. Bacterial cells 
were harvested by centrifugation at 13000 x g for 5 min. QIAquick Plasmid DNA 
Isolation Kit (Qiagen) was used for plasmid DNA isolation.  
2.1.5.2 DNA restriction endonuclease digestion 
The HindIII and PaeI restriction enzymes and Buffer G (Fermentas) were used for 
the digestion of cloned fragment in pJET (Table 2.5). The pJet plasmid constructs 
were digested in a 40 µL reaction volume for three hours. The digestion reaction 
products were analyzed through agarose gel electrophoresis. 
Table 2.5: Components of the DNA restriction endonuclease digestion reaction. 
Component  Volume 
G Buffer 4 µL 
Plasmid 6 µL 
HindIII 2 µL 
PaeI 1 µL 
Water, nuclease-free 27 µL 
Total  40 µL 
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2.1.6 Cloning into expression vector pQE1 
2.1.6.1 Preparation the insert and pQE vector for cloning 
pQE1 expression vector (Qiagen) was also digested with the same restriction 
enzymes and the same conditions as described in section 2.1.5.2. After gel 
electrophoresis and excision from an agarose gel, the digested insert and pQE1 
vector (Figure 2.4) were extracted as described in 2.1.3.  
 
Figure 2.4 : pQE1 vector for N-terminal His tag constructs (Url-3). 
2.1.6.2 Ligation and transformation 
2 µL linearized pQE1 expression vector and 8 µL insert from each discrete eppendorf 
tubes containing DNA fragments including GFPuv, GFPuv-HABP1, GFPuv-
HABP2, GFPuv-HABP1Met and GFPuv-HABP1Ala were added into 500 µL 
eppendorf tubes. Each tubes containing vector and DNA fragment as insert incubated 
at 65 oC 5 minutes. After cooling down on ice, 2µL of ligation 10 X buffer, 2µL of 
T4 DNA ligase (Roche), 6µL of dH2O were added into the same reaction tube.  
Following the incubation at 16°C for 16 hours, heat inactivation was carried out at 
65°C for 10 minutes. The same ligation reaction conditions were applied for all 
GFPuv-HABP constructs. Transformation was performed as desribed in 2.1.4.2.  
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2.1.7 Colony screening for pQE1 constructs 
Colonies were analysed for the presence and orientation of the inserts using the 
restriction and DNA sequence analyses. After selecting and inoculating the bacterial 
colonies, plasmid isolation and resctriction enzyme digestion were done as described 
in 2.1.5.1 and 2.1.5.2 respectively.  
2.1.7.1 DNA sequence analyses 
Plasmids carrying the insert fragments were analyzed with ABI 3300 DNA 
Sequencer (Applied Biosystems). The BigDye Terminator v3.1 Cycle Sequencing 
Kit (Applied Biosystem) was used for sequence PCR. The reaction set up and the 
reaction conditions are given in Table 2.6 and Table 2.7 respectively.  
Table 2.6: Sequence PCR  components. 
Component  Volume 
Ready reaction mix 2 µL 
Plasmid 1 µL 
BigDye Terminator Sequencing Buffer 2 µL 
Promoter Region/Reverse Primer 1 µL 
Water, nuclease-free 4 µL 
Total  10 µL 
Table 2.7: Sequence PCR conditions. 
Temperature Time Cycle 
95 oC 5 min 1 
95 oC 10 sec 
50 oC 30 sec 
60 oC 4 min 
 
15 
1 µL of 3M sodium acetate (pH 5.5) and 25 µL 95 % ethanol were added into each 
sequence PCR product. The tubes were incubated on ice for 15 minutes and 
centrifuged for 15 minutes  at 14000 rpm . Supernatant was discarded and DNA 
pellet was washed with 250 µL cold 70 % ethanol. Samples were centrifuged for 15 
minutes at 14000 rpm. Ethanol was discarded and the DNA pellet was dried at 37 oC. 
20 µL di-formamide was added to each tube. Samples were incubated at 95 oC for 3 
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minutes for denaturating.  After vortexing, the samples were keeped at 4oC until the 
loading.  
2.1.8 Expression of histidine tagged GFPuv protein and GFPuv-HABP1,  
GFPuv-HABP2, GFPuv-HABP1Met, GFPuv-HABP1Ala fusion proteins in E. 
coli TOP10 bacteria 
2.1.8.1 Overnight culture preparation and inoculation 
Glycerol stock of recombinant E. coli Top10F’ strains harboring pQE1GFPuv, 
pQE1GFPuv-HABP1, pQE1GFPuv-HABP2, pQE1GFPuv-HABP1Met and 
pQE1GFPuv-HABP1Ala expression constructs were streaked out onto LB-agar 
medium plates containing ampicillin (100 µg/mL). The plates were grown overnight 
at 37 °C. A single colony was selected for the starter culture. 10 mL starter cultures 
were grown overnight in LB medium  supplemented with ampicillin (100 µg/mL) at 
37 oC by shaking at 200 rpm.  
2.1.8.2 Expression conditions for pQE1 constructs 
Expression of each protein construct was performed according to PQE vector 
instructions (Qiagen). 100 ml of prewarmed LB medium was inoculated with 5 ml of 
the overnight culture, and grown at 37 oC by shaking at 200 rpm, until an OD600 of 
0.5-0.7 was reached. Expression was induced by adding IPTG to a final 
concentration of 1 mM. The culture was grown for an additional 4 h. 
2.1.9 Preparation of glycerol stock for transformant colonies 
2 mL of overnight culture was spun down with 5000 rpm and the supernatant was 
removed. Cell pellet was resuspended in LB medium containing 15 % Glycerol. 
After transferring to a sterile screw cap microcentrifuge tube, the stock was stored at 
-80 oC. 
2.1.10 Fluorescence microscopy imaging of GFPuv protein and GFPuv-HABP1,  
GFPuv-HABP2, GFPuv-HABP1Met, GFPuv-HABP1Ala fusion proteins 
The GFPuv, GFPuv-HABP1, GFPuv-HABP2, GFPuv-HABP1Met and GFPuv-
HABPAla expressing cells were monitored using an epifluorescence microscope 
(BX60, Olympus Corp. Japan (Figure 2.5)) equipped with a U-MWIB filter cube 
(Olympus Corp. Japan).  
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Figure 2.5 : The setup for fluorescence microscope. 
Induced culture samples were centrifuged at 5,000xg for 2 min and the pellets were 
washed several times with phosphate-buffered saline (PBS) solution (137 mM NaCl, 
2.7 mM KCl, 10 mM Na2HPO4, 2 mM KH2PO4 ). The pellets were then gently 
suspended in PBS solution, and the suspension was deposited on a glass slide to 
observe the fluorescence activity of the samples. A cooled CCD camera (Diagnostic 
Instrument) and Spot Advanced software were used to capture the images of 
samples. 
2.1.11 Purification of histidine tagged proteins 
2.1.11.1 Preparation of  E. coli lysates under native conditions 
The grown culture was transferred to centrifuge tubes. Cells were harvested by 
centrifugation for 1 minute at 15.000xg, and  the supernatant was discarded. 
Harvested cells were resuspended in 5 ml of lysis buffer (50 mM NaH2PO4, 300 mM 
NaCl, 10 mM imidazole, pH: 8.0). Lysozyme was added to 1 mg/mL, and the sample 
was incubated on ice for 30 minutes. Then, the lysate was sonicated six times for 10 
s with 10s pauses at 200 W. Samples were kept on ice at all times.  
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2.1.11.2 Batch purification of histidine tagged proteins 
Bacterial lysate was centrifuged at 10.000xg at 4 oC for 20 minutes and the 
supernatant was decanted. 2 mL of a 50% slurry of Ni-NTA resin (Qiagen) was 
added to supernatant and the tube was mixed gently for 30 minutes at 4 oC. The 
mixture was centrifuged for 10 s at 1000xg to pellet the resin and supernatant was 
discarded. The resin was washed twice with 100 µL wash buffer (50 mM NaH2PO4, 
300 mM NaCl, 20 mM imidazole pH:8.0) and the protein was eluted three times with 
20 µL elution buffer (50 mM NaH2PO4, 300 mM NaCl, 250 mM imidazole pH:8.0). 
Protein assay was performed by Bradford assay (Sigma) according to the 
manifacturer’s instructions. 
2.1.11.3 SDS-Polyacrylamide  gel electrophoresis 
Protein samples were analyzed by SDS-polyacrylamide gel electrophoresis (SDS-
PAGE) with a discontinuous buffer system. Seperating and stacking gel parts were 
prepared by mixing the components stated  in Tables 2.8 and 2.9.  
Seperating gel acrylamide mix was poured into the gap between the glass plates and 
sufficient space was left for the stacking gel solution. After polimerization, stacking 
gel solution was poured and a comb was inserted. 
10 µL of each sample was mixed with 4 µL of loading dye (Fermentas) and 
denaturated at 95 °C for 5 minutes. Protein samples and the molecular weight marker 
(Appendix A2, Fermentas) were run at 80 volt for stacking gel and 150 volt for 
seperating gel. 
Table 2.8: Components for preparing 12%  resolving gel for SDS-PAGE. 
Component Volume 
ddH2O 1.6 µL 
30% acrylamide mix 2.0 µL 
1.5 M Tris (pH 8.8) 1.3 µL 
10% SDS 0.05 µL 
10% ammonium persulfate 0.05 µL 
TEMED 0.002 µL 
Total 2 µL 
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Table 2.9: Components for preparing 5%  stacking gel for SDS-PAGE. 
Component Volume 
ddH2O 0.68 µL 
30% acrylamide mix 0.17 µL 
1.5 M Tris (pH 8.8) 0.13 µL 
10% SDS 0.01 µL 
10% ammonium persulfate 0.01 µL 
TEMED 0.001 µL 
Total 1 µL 
2.1.12 Spectrofluorophotometric and physicochemical analyses  of GFPuv and 
GFPuv-HABP proteins 
The excitation, emission wavelengths and fluorescence properties of the proteins 
were compared with a control GFPuv using Shimadzu RF-5301 PC 
spectrofluorophotometer  (Figure 2.6), with the wavelength range of 220 to 750 nm.  
 
Figure 2.6 : Shimadzu RF-5301 PC spectrofluorophotometer. 
Isoelectric point (pI) and molecular weight (MW) of the proteins was calculated by 
ExPasy ProtParam tool (Url-4). 
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2.1.13 Binding of GFPuv-HABP fusion constructs to hydroxyapatite 
2.1.13.1 Cleaning HA powder 
Synthetic HA powder (Sigma-Aldrich) was used for binding experiments. A 10-mg 
powder was suspended in 100 µL distilled water and a 900 µL of 1:1 
methanol/acetone mixture. After vortexing, the suspension was sonicated for 20 
minutes and then the procedure was repeated using isopropanol. Next, the powder 
was washed with phosphate/sodium carbonate (PC) buffer (55 mM KH2PO4, 45 mM 
Na2CO3, 200 mM NaCl pH 7.4) followed by drying in vacuum. 
2.1.13.2 Incubation proteins with HA powder 
Cleaned HA powder was incubated overnight with purified GFPuv, GFPuv-HABP1, 
GFPuv-HABP2, GFPuv-HABP1Met  and GFPuv-HABP1Ala at 4 µM concentration  
in PC buffer containing 0.1% detergent (Tween 20 and 80, Merck) at room 
temperature and with constant rotation using a rotary mixer (Rotator STR4, Stuart 
Scientific) at 20 rpm for 4 hours.  
2.1.13.3 Monitoring binding 
After the incubation step, protein solutions with HA powder were centrifuged at 
200xg for 3 min at room temperature. The pellets were then washed several times 
with PC buffer containing 0.1% detergent.  After removing the supernatant, the 
GFPuv-bound HA samples were transferred to a microscope slide and examined 
under epifluorescence microscope (BX60, Olympus Corp. Japan). 
2.1.14 Circular dichroism (CD) spectropolarimeter analysis of GFPuv-HABP 
constructs 
The secondary structure analyses of the constructs were carried out using a Jasco J-
810 circular dichroism (CD) spectropolarimeter (Jasco, Easton, MD, USA). The 
wavelength CD scans were recorded from 200-260 nm, and the scan parameters were 
set at 1 nm step size, 1 nm band width, 50 nm/min speed and 2 sec response time. 
The protein samples of 20 µM were prepared in PC buffer (pH 7), and their CD 
spectra were measured in the 1 mm path-length CD quartz cuvette (Starna Cells) at 
room temperature. For each spectrum, 3 scans were averaged after the background 
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subtraction of the buffer-alone sample. The mean residue molar ellipticity [θM] is 
expressed in deg * cm2dmol–1. 
2.1.15 Quartz crystal microbalance analysis of  GFPuv-HABP constructs 
The quantitative binding of GFPuv, GFPuv-HABP1 and GFPuv-HABP2 on to HA 
substrate was carried out using a QCM-D (Quartz Crystal Microbalance with 
Dissipation Monitoring) system from KSV Instruments (KSV Instruments, Finland), 
equipped with a flow cell and a peristaltic pump (Figures 2.7 and 2.8).  
 
Figure 2.7 : The setup for QCM. 
 
Figure 2.8 : Server-client architecture. The QCM flow cell, through which 
initially the buffer to clean the system, and then the tested 
sample solution at increasing concentration are channeled. 
HA-coated QCM-D (Q-Sense, Switzerland) quartz crystals, cleaned using 96% (v/v) 
ethanol and deionized water were used. The cleaned crystals were mounted in QCM-
D instrument and binding properties of the peptides were recorded as a function of 
time. The protein constructs were prepared in PC buffer at various concentrations of 
300, 500, 1500 and 3000 nM. The protein solutions were introduced into the 
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chamber of QCM-D in a sequential order, following the baseline equilibration using 
PC buffer.   
2.1.16 Labelling mineralized tissues 
Teeth samples were kept in 70% ethanol. The specimens were sterilized by 
ultrasonicating in isopropyl alcohol several times to remove any organic remains or 
calculus from the tooth surface and expose the mineralized, native surface. 
Cylindrical pieces were cut from the acellular afibrillar cementum (AAFC), close to 
the cemento-enamel junction (Figure 2.9). 
Cylindrical pieces incubated with protein samples were examined using a SEM. The 
cylindrical teeth samples were incubated with 1.4 µM GFPuv, GFPuv-HABP1 and 
GFPuv-HABP2-containing solutions. After incubation at room temperature for 2 h, 
samples were rinsed twice in wash buffer containing 0.1% detergent and once in 24 
mM tris buffer (pH 7.4). Fluorescent microscopy with a Nikon Eclipse TE2000-U 
(Nikon, USA) microscope and the appropriate fluorescent filter (i.e., exciter 460-500, 
emitter 510-560, Chroma Technology Co., USA) was used.  
 
Figure 2.9 : Schematic description of the procedure for cutting cylindirical 
specimens from the root. 
The average relative fluorescent intensities were measured real-time using 
Metamorph v7.5 image processing software (Molecular Devices, USA).  
2.1.17 Time-wise monitoring of mineralization on surfaces 
2.1.17.1 Preparation of calcium phosphate mineral covered glass slides 
Mineral layers were formed according to an alkaline phosphatase (AP)-based 
mineralization model (Gungormus et al. 2008). This model involves enzymatic 
hydrolysis of an organic phosphate compound, namely β-Glycerophosphate (β-GP), 
to PO4-3 by AP.  
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Mineralization solution was prepared using 24 mM Ca+2 (CaCl2) and 14.4 mM β-GP 
in 25mM Tris-HCl buffer (pH 7.4). When PO4-3 is released to the solution by the 
action of AP, Ca/P mineralized composition is produced. Following the 
mineralization reactions, calcium phosphate layers were formed on glass cover slides 
(Figure 2.10). Samples were examined by optical microscopy using a Nikon Eclipse 
TE2000-U (Nikon, USA) and scanning electron microscopy (SEM, JSM 7000F 
JEOL-) at different time intervals, including 0.5, 2, 8 and 24 hours. Upon completion 
of each time interval, the glass slides were taken out and the mineral covered areas 
on glass slides were determined using Metamorph v7.5 image processing software 
(Molecular Devices, USA). 
 
Figure 2.10 : Glass coverslides on which calcium phosphate layers were 
formed following the mineralization reactions. 
2.1.17.2 Incubation protein samples with mineral covered glass slides 
Following determination of mineral covered areas, slides were incubated with 1.4 
µM GFPuv and GFPuv-HABP1 (in 24 mM Tris-HCl buffer, pH 7.4) for 2 hours at 
room temperature. Then, the slides were rinsed twice in wash buffer containing 0.1% 
detergent (Tween 20 and 80) and once in Tris-HCl buffer ( 24 mM; pH: 7.4 ). 
Samples were monitored under fluorescent microscopy (Nikon Eclipse TE2000-U 
(Nikon, USA) with fluorescent filters (exciter 460-500, emitter 510-560, Chroma 
Technology Co., USA). 
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2.2 Construction, Expression and Analyses of MBP Tagged GFPuv Fusion 
Proteins 
2.2.1 Oligonucleotide primers for GFPuv, GFPuv-AgBP2c and GFPuv-AuBP2c  
constructs 
Primers for constructing GFPuv-AuBP (CGP-WALRRSIRRQSY-GPC) and GFPuv-
AgBP (CGP-EQLGVRKELRGV-GPC) fusion proteins encoding expression vector 
were designed (Table 2.10).  
Table 2.10: Oligonucleotide primers used in PCR reactions for GFPuv, GFPuv-
AgBP2c and GFPuv-AuBP2c  constructs. 
Primer 
Name 
Sequence 
AuP1 5’ – CGAACGACGCAGAGCCCACGGACCGCAACCTCCA CCCGATTTGTAGAGCTCATCCATGCC – 3’ 
AuP2 5’- CGAACGACGCAGAGCCCACGG -3’                                                                              
AuP3 5’- GCCAAGCTTTTAGCACGGACCATACGACTGACGAC 
GAATCGAACGACGCAGAGCCCA -3’ 
AuP4 5’- GCCAAGCTTTTAGCACGGACCATA -3’ 
PMGFP1 5’ - CGGGAATTCATGAGTAAAGGAGAAGAACTT - 3’ 
PMGFP2 5’-  GCCAAGCTTTTATTTGTAGAGCTCATCCATGCC- 3’ 
AgP1 5’-ACGCACACCCAGCTGTTCCGGACCGCAACCTCCAC 
CCGATTTGTAGAGCTCATCCATGCC-3’ 
AgP2 5’-ACGCACACCCAGCTGTTCCGG-3’ 
AgP3 5’-GCCAAGCTTTTAGCACGGACCCACACCACGCAGTTCT 
TTACGCACACCCAGCTGTTC-3’ 
AgP4 5’-GCCAAGCTTTTAGCACGGACCCACACCACG-3’ 
2.2.2 Polymerase chain reaction for GFPuv, GFPuv-AgBP2c and GFPuv-
AuBP2c DNA fragments 
The vector pGFPuv used as a template in all polymerase chain reactions (PCR). The 
PCR experiments were performed using, Phusion High-fidelity DNA polymerase 
(NEB). This enzyme generates blunt ends in the amplification products. To obtain A-
added fragments, Taq DNA polymerase (NEB) was added into the reaction before 
the final extension. 
GFPuv encoding sequence was amplified using the forward PMGFP1 and the reverse 
PMGFP2 primers containing extra residues including a EcoRI or HindIII site at their 
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5’ ends, respectively. The DNA fragment encoding GFPuv-fused silver binding 
peptide AgBP2c (GFPuv-AgBP2c) and GFPuv-fused gold binder peptide AuBP2c 
(GFPuv-AuBP2c) were obtained in a four step PCR reactions.  
The first PCR reaction was kept in 15 cycle and performed by using the forward 
primer PMGFP1 and the reverse primer AuP1 bearing the first part of gold binding 
peptide (AuBP2c) coding sequence (Table 2.10 and 2.11).  
Table 2.11: Conditions for the first and third PCR steps for GFPuv-AuBP2c and 
GFPuv-AgBP2c constructs. 
Temperature Time Cycle 
98 oC 30 s 1 
98 oC 10 s 
50 oC 10 s 
72 oC 2 min 
 
15 
72 oC 5 min 1 
The second PCR reaction was kept in 30 cycle and performed by using the forward 
primer PMGFP1 and the reverse primer AuP2 and the first PCR product as a 
template (Table 2.12). The PCR product was purified by gel extraction and used as a 
template for the third PCR reaction. The third PCR reaction was kept in 15 cycle and  
performed by using the forward primer PMGFP1 and the reverse primer AuP3 
bearing the second part of AuBP2c coding sequence with HindIII cleavage site 
(Table 2.11). The fourth PCR reaction was kept in 30 cycle and performed by using 
the forward primer PMGFP1 and the reverse primer AuP4 and the third PCR product 
as a template (Table 2.12). 
Using the same PCR strategy described above, the DNA fragment encoding GFPuv 
fused silver binding peptide AgBP2c (GFPuv-AgBP2c) was obtained. PMGFP1, 
AgP1, AgP2, AgP3 and AgP4 primers were used with the same order. 
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Table 2.12: Conditions for the second and fourth PCR step for GFPuv-AuBP2c 
and GFPuv-AgBP2c constructs. 
Temperature Time Cycle 
98 oC 30 s 1 
98 oC 10 s 
54 oC 30 s 
72 oC 30 s 
 
30 
72 oC 10 min 1 
2.2.3 Cloning PCR products into TOPO TA cloning vector 
2.2.3.1 Ligation and  electroporation 
Purified DNA fragments were cloned into TOPO TA cloning vector (pCR2.1-TOPO, 
Invitrogen (Figure2.11)). 
 
Figure 2.11 : Map of TOPO TA Cloning Vector (Url-5). 
Table 2.13 describes the set up for  TOPO TA cloning reaction. After mixing, the 
reaction was incubated for 15 minutes at room temperature.  
Table 2.13: TOPO TA cloning setting up. 
Reagent Volume 
PCR Product 3 µL 
Diluted Salt Solution 1 µL 
Water 1 µL 
TOPO vector 1 µL 
Total  6 µL 
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TOPO cloning constructs were transformed into E. coli TOP10 F’ as decribed in 
Section 2.1.4.1. After electroporation and incubation cells were spread on pre-
warmed selective X-gal/IPTG LB plate containing 100 µg/mL ampicillin.  
2.2.3.2 Colony screening 
An afficient TOPO TA cloning reaction produces several hundred blue or white 
colonies on the selective plate (Url-5). 10-20 white colonies were taken and cultured 
overnight in LB medium containing 100 µg/mL ampicillin. After isolation, plasmids 
were analyzed by restriction analyses using EcoRI and HindIII restriction enzymes as 
described section 2.1.5.2 (Fermentas).  
2.2.4 Cloning into expression vector pMALc4x 
2.2.4.1 Preparation insert and pMALc4x vector 
pMALc4x expression vector (NEB) was also digested with the same restriction 
enzymes as described  above.  After gel electrophoresis, digested inserts (GFPuv, 
GFPuv-AgBP2c, GFPuv-AuBP2c) and pMALc4x vector were extracted from 
agarose gel. 
2.2.4.2 Preparation competent E.coli ER2507 using rubidium chloride method 
Overnight culture was subcultured at 1:100 in  100 mL of LB + 20 mM MgSO4 and 
grown  until  OD600 reached 0.6. The culture was centrifuged at 5.000xg for 5 
minutes at 4 oC. Cell pellet was resuspended 40 mL cold TFBI (30 mM KOAc, 100 
mM RbCl, 10 mM CaCl2, 50 mM MnCl2, 15 % glycerol, pH 5.8 ) and incubated on 
ice for 5 minutes. After centrifugation at 5.000x for 5 minutes, the pellet was 
resuspended in 4 ml of TFB2 (10 mM MOPS, 75 mM CaCl2, 10mM RbCl, 15% 
glycerol, pH 6.5 ) and incubated on ice 30 minutes. 80 µL aliquots of cells were 
prepared in 1.5 mL eppendorf tubes and frozen in liquid N2  and stored at -80 °C. 
2.2.4.3 Ligation and transformation 
Quick ligation kit (NEB) was used for ligation. The components of ligation was 
combined acording to Table 2.14. 
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3 µL of reaction was used for each transformation. After thawing an aliquot of 
competent bacterial cells on ice, ligation reaction was added and the mixture was 
incubated 1 hour on ice. 
Table 2.14: Reaction components for pMALc4x ligation. 
Component  Volume 
pMALc4x 3 µL 
Insert 7 µL 
2x Quick Ligation Reaction Buffer 10 µL 
Quick T4 DNA Ligase 1 µL 
Total  21 µL 
Following a heat shock at 37 oC for 45 seconds, cells were incubated on ice for 2 
minutes. 1 mL of LB was added and the cells incubated at 37 oC for 20 minutes. 100 
µL of culture was spread on LB plate containing 100 µg/mL ampicillin. The LB plate 
was incubated at 37 °C over night. 
2.2.4.4 Colony screenig 
Colonies were analysed for the presence and orientation of the inserts using 
restriction and DNA sequence analyses. 
2.2.5 Expression of MBP tagged GFPuv protein and GFPuv-AgBP2c, GFPuv-
AuBP2c fusion proteins in E. coli ER2507 bacteria 
1 liter of LB medium with 2 % glucose supplemented with 100 µg/mL ampicillin 
was inoculated with recombinant ER2507 E. coli bacteria harboring pMALc4x 
constructs. Each  recombinant cell culture containing one of the pMALc4x constructs 
(pMALc4x-GFPuv, pMALc4x-GFPuv-AgBP2c, pMALc4x-GFPuv-AuBP2c) were 
grown  at 37 °C  until OD600 reached 0.5, after which IPTG was added to a final 
concentration of 0.3 mM. After induction, each culture incubated at 30 oC for 6 
hours. 
2.2.6 Purification of MBP tagged proteins 
Following expression, cells were harvested by centrifugation at 4000xg for 20 
minutes. The cell pellet was resuspended in 50 mL column buffer and frozen 
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overnight at -20 oC. Cells were then thawed in cold water and sonicated as described 
in 2.1.11.1. 
After centrifugation at 9,000xg for 30 minutes, supernatant was saved and diluted at 
1:5 with column buffer (20 mM Tris-HCl, 200 mM NaCl, 1mM EDTA). 10 ml 
amylose resin (NEB) was poured in a 2.5x10 cm colum. Column was washed with 8 
column volumes of column buffer. Filtered supernatant sample was loaded to 
amylose column for the affinity chromatograpy (Figure 2.12) at a flow rate of 1 
ml/minute. 
 
Figure 2.12 : Set up for affinity chromatography. 
Following the washing of the column with 12 column volumes of column buffer, the 
protein of interest was eluted using column buffer with 10 mM maltose. Fractions 
were collected and concentrated by 10 kDa Amicon Ultra-15 protein centrifugal filter 
(Milipore, USA).  
2.2.7 Cleavage of MBP tag 
Purified MBP-GFPuv, MBP-GFPuv-AgBP2c and MBP-GFPuv-AuBP2c proteins 
were concentrated by Amicon Ultra-15 protein centrifugal filter to 1 mg/mL. Protein 
samples were transferred to buffer containing 20 mM Tris-HCl, 100 mM NaCl, 2 
mM CaCl2 (pH 8.0) by ultrafiltration using the same centrifugal filter tubes. 40 µL of 
1mg/mL Factor Xa (NEB) was added to 2.5 ml fusion protein substrate. The reaction 
was incubated at 4 oC overnight and then at room temperature for 3 hours.  
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2.2.7.1 Removal of maltose by hydroxyapatite chromatography 
2 g hydroxyapatite was swollen in 20 mM sodium phosphate, 200 mM NaCl (pH 
7.2). Swollen hydroxyapatite was washed with the same buffer and poured into the 
column.  
Each fusion protein cleavage mixture was loaded onto the column. Using 80 mL of 
the same buffer, the column was washed and maltose was washed away. Protein 
samples were eluted with 0.5 M Na phosphate (pH 7.2). 
2.2.7.2 Analysis for the purified MBP-GFPuv, MBP-GFPuv-AgBP2c, MBP-
GFPuv-AuBP2c, GFPuv, GFPuv-AgBP2c and GFPuv-AuBP2c proteins 
Hydroxyapatite-eluted protein was loaded onto the amylose column as described 
2.2.7.1. Protein samples in the flow-through should be free of MBP. Protein assay 
was performed by Bradford assay (Sigma) according to manifacturer’s instruction. 
SDS-PAGE and spectrofluorophotometric analyses were done as desribed in 2.1.11.3 
and 2.1.12, respectively. 
2.2.8 Microcontact Printing of MBP-GFPuv and MBP-GFPuv-Metal Binding 
Peptides 
The PDMS stamps were fabricated by molding a mixture of  pre-polymer 
polydimethyl siloxane and curing agent with a ratio of 10:1 (w/w) (Sylgard 184, 
Dow Corning, USA) on the patterned silanized master. The stamps were then washed 
several times with ethanol, heptane, and last with ethanol, and dried with nitrogen. 
The patterned side of the PDMS stamp is incubated with MBP-GFP-AgBP, MBP-
GFP-AuBP and MBP-GFP. After drying, the stamps were applied to silver and gold 
substrates. Then the stamps were removed from the substrates. 
2.2.9 Self Assembly of Fusion Proteins on Silver Nanoparticle-arrayed Surface 
Quartz binding peptide-PPP-Silver Binding Peptide (QBP-PPP-AgBP) was 
microcontact printed on the glass cover slides as described above. QBP-PPP-AgBP 
printed substrate was incubated with 80 nm and 20 nm AgNP. After 30 minutes 
incubation, the substrates were washed and dried under nitrogen. The silver 
nanoparticle arrays were observed under dark field microscopy. Silver patterned 
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surfaces were incubated with MBP-GFPuv-AgBP2c, GFPuv-AgBP2c, MBP-GFPuv 
and GFPuv.  
2.2.10 Fluorescence Quenching/Enhancement by Metallic Nanoparticles 
Fluorescent measurements were performed using TECAN Safire UV-vis 
spectrometer microplate reader (Figure 2.14). 384 well black clear flat bottom 
microplate (Corning) was used for the incubation and fluorescent measurements. 5 
µL (10 µM) protein was incubated with gold nanoparticles with different total 
surface area in the 50 µl total reaction volume. After incubation, fluorescence 
intensity was measured at 394 nm excitation and 510 nm emission wavelengths. 
 
Figure 2.13 : The spectrophotometer. 
.  
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3.  RESULTS AND DISCUSSION 
3.1 Genetic Construction and Applications of Histidine Tagged GFPuv-HABP 
Fusion Proteins 
In this study, fusion proteins encoding both the fluorescence activity of a GFP 
variant and hydroxyapatite-binding activity of phage display selected peptides have 
been engineered. Each fusion peptide was cloned into pQE1 expression vector 
encoding N-terminal Histidine tag. 
In widely used phage display libraries (New England Biolab), 7 or 12 amino acid 
long peptides are displayed at the N-terminus of pIII coat protein. The displayed 
peptide sequences are separated from the pIII protein by short flexible SGGG linker 
(Brown et al., 2000; Tamerler et al., 2010) . In this study a flexible SGGG linker was 
used between GFP and HABPs (Figure 3.1). 
There are many of studies in literature exploiting fluorescent protein fusions. In most 
of these studies it has been observed that fusion of GFP to the protein of interest does 
not alter the function of both GFP and the protein (Hoffman 2002; Zimmer 2002; 
Chudakov et al., 2005; Wiedenmann et al., 2009). In previous studies, it has been 
demonstrated that the single form or multiple repeat of inorganic binding peptides 
conserved their binding ability when they fused to functional proteins (Park et al., 
2006; Kacar et al., 2009b). In this study it has been demonstrated that GFPuv-
HABP1 construct conserved both fluorescence and HA binding activity. 
GFPuv-HABP1 with multifunctional property, has been exploited for targeted 
labeling of mineralization on the synthetically mineralized surface and the naturally 
mineralized tissue. 
3.1.1 Designing GFPuv-HABP fusion constructs 
In order to generate GFPuv and GFPuv-HABP constructs, primers were designed 
according to amino acid sequence of HABPs, -SGGG linker and GFPuv. Multiple 
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cloning site of expression vector pQE1 has various restriction endonuclease cleavage 
sites including PaeI and HindIII. 
GFPuv and GFPuv-HABP encoding sequences were amplified using a series of 
forward and reverse primers containing extra residues including a PaeI or HindIII 
site at their 5’ ends respectively. As the constructs were cloned into pQE1 vector 
coding N-terminal His tag, in the final purified proteins, histidine tag was placed at 
the N terminal, while HABPs were located at the C- terminal (Figure 3.1). 
 
Figure 3.1 : Designing strategies of GFPuv-HABP fusion proteins. A. GFP-GEPI 
fusion. Modified from PDB ID: 1b9c. B. Schematic representation of 
the designing strategy. 
3.1.2 Obtaining PCR products encoding GFPuv and GFPuv-HABP fusion 
proteins 
The DNA fragment encoding GFPuv and GFPuv-HABPs were obtained by single 
and consecutive PCR reactions, respectively. Various conditions were applied for 
PCR to obtain the desired molecular weight. The GFPuv, GFPuv-HABP1/2 and 
GFPuv-HABPAla/Met PCR products were 735 bp, 774 bp and 768 bp respectively. 
PCR conditions were optimized for the fusion constructs. It was observed that when 
pfu polymerase was used, 50 oC was the optimum annealing temperature for the first 
step of PCR. 
Using agarose gel electrophoresis, the molecular weight of GFPuv, GFPuv-HABP1, 
GFPuv-HABP2, GFPuv-HABP1Ala and GFPuv-HABP1Met encoding DNA 
fragments were verified (Figures 3.2, 3.3, 3.4 and 3.5). 
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Figure 3.2 : Fragments amplified with pfu DNA polymerase; lane 1. Lambda 
DNA/EcoRI+HindIII Marker, 3 (Fermentas), lane 2. GFPuv 
encoding DNA fragment, lane 3. Control. 
 
Figure 3.3 : Fragments amplified with pfu DNA polymerase; lane 1. ϕX174 
DNA/HinfI Marker, 10 (Fermentas), lane 2. Control lane, 3. 
Hydroxyapatide binding peptide 1-GFPuv encoding DNA fragment, 
lane 4. GFPuv encoding fragment. 
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Figure 3.4 : Fragments amplified with pfu DNA polymerase; lane 1. ϕX174 
DNA/HinfI Marker, 10 (Fermentas), lane 2. Control, lane 3. 
Hydroxyapatide binding peptide 2-GFPuv encoding DNA fragment. 
 
Figure 3.5 : Fragments amplified with Pfu DNA polymerase; lane 1. Mass Ruler 
DNA Ladder mix (Fermentas), lane 2. Control, lane 3. GFPuv-
HABP1Ala (AGHHPLM), lane 4. GFPuv-HABP1Met (MLPHHGA) 
encoding DNA fragment. 
3.1.3 Cloning the target DNA into pJET cloning vector 
Using cloning vector, insert DNA can be carried and introduced into the bacteria. In 
this method, numerous copies of insert can be produced. After extraction of the PCR 
products from agarose gel, each purified DNA fragment was ligated into pJET 
cloning vector. After transformation of E. coli TOP10 F’ cells with the ligation 
product, colonies were observed on agar plates containing ampicillin. 
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3.1.3.1 Positive selection for the transformant colonies 
pJet cloning vector provides a positive selection strategy by containing the gene for a 
restriction endonuclease which is lethal for the E.coli strains used for cloning. 
Disrupting the lethal gene by the ligation reaction leads to amplification of only cells 
with recombinant plasmids (Url-2). 
pJET vectors harboring GFPuv, GFPuv-HABP1, GFPuv-HABP2, GFPuv-
HABP1Ala, GFPuv-HABP1Met inserts were isolated from selected colonies. These 
plasmids were digested with PaeI and HindIII to obtain the insert DNA fragments. 
Double digestion products were run in agarose gel (Figures 3.6, 3.7, 3.8 and 3.9). 
 
Figure 3.6 : Verification of cloning of gfpuv-HABP1 into pJET cloning vector. 
Undigested and double digested recombinant pJET plasmids 
harboring gfpuv-HABP1 were loaded into the gel sequentially. 
 
Figure 3.7 : Verification of cloning of gfpuv-HABP2 into pJET cloning vector. 
Undigested and double digested recombinant pJET plasmids 
harboring gfpuv-HABP2 were loaded into the gel sequentially. 
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Figure 3.8 : Verification of cloning of gfpuv-HABP1Met into pJET cloning 
vector. Undigested and double digested recombinant pJET plasmids 
harboring gfpuv-HABP1Met were loaded into the gel sequentially. 
 
Figure 3.9 : Verification of cloning of gfpuv-HABP1Ala into pJET cloning 
vector. Undigested and double digested recombinant pJET plasmids 
harboring gfpuv-HABP1Ala were loaded into the gel sequentially. 
Digested and undigested pJET vectors harboring GFPuv, GFPuv-HABP1, GFPuv-
HABP2, GFPuv-HABP1Ala, GFPuv-HABP1Met inserts were run in an agarose gel 
and size of insert fragments were verified (Figures 3.6, 3.7, 3.8 and 3.9). 
3.1.4 Generating histidine tagged GFPuv protein and GFPuv-HABP1, GFPuv-
HABP2, GFPuv-HABP1Met, GFPuv-HABP1Ala fusion protein expressing 
bacteria 
Recombinant E. coli Top10F’ strains harboring 6His-GFPuv, 6His-GFPuv-HABP1, 
6His-GFPuv-HABP2, 6His-GFPuv-HABP1Ala and 6His-GFPuv-HABP1Met 
expression constructs were obtained by cloning the each DNA fragment into pQE1 
expression vector and transforming the bacteria with the constructs. 
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3.1.4.1 Cloning into expression vector pQE1 
pQE1 vector having ColE1 origin of replication (Url-3) was exploited for high-level 
expression of His-tagged GFPuv and GFPuv-HABP proteins in E. coli. GFPuv and 
GFPuv-HABP encoding sticky ended DNA fragments were obtained by digesting the 
recombinant pJET plasmids. pQE1 vector was also linearized by the same restriction 
enzymes. Sticky ended insert fragments (gfpuv, gfpuv-HABP1, gfpuv-HABP2, gfpuv-
HABP1Ala, gfpuv-HABP1Met) and pQE1 vector were run into agarose gel. After gel 
extraction, all fragments were again run into the gel and purification of the DNA 
fragments were verified. Purified gfpuv-HABP1 DNA fragment is shown in Figure 
3.10. 
 
Figure 3.10 : Purifired gfpuv-HABP1 fragment. After gel extraction, insert 
fragments were run into 1% agarose gel and purification of the 
DNA fragments was verified. 
Following the ligation reactions, E. coli TOP10 F’ electrocompetent cells were 
transformed with each ligation product. Recombinant colonies were selected on 
ampicillin including LB plates. For each construct, more than 50 colonies were 
observed on the plate after overnight incubation. 
3.1.4.2 Colony Screening after transformation 
The resulting transformant colonies were picked up and replicated. Bacterial cultures 
inoculated with the selected colonies were used for plasmid isolation. Insertion of 
gfpuv, gfpuv-HABP1, gfpuv-HABP2, gfpuv-HABP1Ala, gfpuv-HABP1Met 
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fragments into PQE1 was verified by digestion of purified plasmids with PaeI and 
HindIII. Insertion of the insert fragments into PQE1 expression vector is indicated by 
Figures 3.11, 3.12, 3.13. 
 
Figure 3.11 : Verification of cloning of gfpuv into pQE1 expression vector. 
Undigested and double digested recombinant pQE1 plasmids 
harboring gfpuv were loaded into the gel sequentially. 
After insert verification, the sequences of pQE1 constructs harboring the insert 
fragments were confirmed by DNA sequence analyses. It has been demonstrated that 
the pQE1GFPuv and pQE1GFPuv-HABP constructs do not carry any mutation. 
 
Figure 3.12 : Verification of cloning of gfpuv-HABP1 into pQE1 expression 
vector. Undigested and double digested recombinant pQE1 
plasmids harboring gfpuv-HABP1 were loaded into the gel 
sequentially. 
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Figure 3.13 : Verification of cloning of gfpuv-HABP2 (A) and gfpuv-HABP1Ala 
(B) into pQE1 expression vector. 
Transformant colonies were also monitored under UV light. After transformation, 
transformant colonies were picked up by sterile toothpick by touching the colonies. 
After lightly dragging the toothpick to plate surface, replica plates were incubated 
overnight. 
For each construct, one of the replica plates contained IPTG for inducing 
recombinant protein production. IPTG containing replica plates were examined 
under UV light and gfp based fusion protein expressing bacterial colonies were 
monitored (Figure 3.14). 
 
Figure 3.14 : After transformation, transformant colonies were picked up. IPTG 
containing replica plates were examined under UV light (A) and gfp 
based fusion protein expressing bacterial colonies were monitored. 
B) Image of replica plate under visible light. 
 66 
3.1.5 Production and Purification of The Recombinant Histidine Tagged 
Proteins 
6His-GFPuv, 6His-GFPuv-HABP1, 6His-GFPuv-HABP2, 6His-GFPuv-HABP1Ala 
and 6His-GFPuv-HABP1Met fusion proteins were expressed in E. coli TOP10 F´ 
strains. Colonies were grown in ampicillin containing LB medium and were induced 
with IPTG for overexpression of the his-tagged proteins. After cell lysing, 
overexpressed proteins were purified using Ni-NTA resin. The expression level, 
purity and molecular weights of fusion proteins were analyzed by SDS-PAGE 
(Figures 3.15, 3.16 and 3.17). 
 
Figure 3.15 : SDS-PAGE analysis of the protein samples extracted from GFPuv 
(Lanes 2-5) and GFPuv-HABP1 (Lanes 6-9) expressing E. coli 
TOP10 F’. Lane 1- molecular weight marker, lanes 2 and 6 - total 
protein, lanes 3 and 7 - supernatant of the cell extract (soluble 
proteins), lanes 4 and 8 – pellet of the cell extract, lanes 5 and 9 - 
purified GFPuv and GFPuv-HABP1 proteins. 
 
Figure 3.16 : SDS-PAGE analysis of purified GFPuv and GFPuv-HABP1 
proteins. 
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Figure 3.17 : SDS-PAGE analysis of purified GFPuv-HABP2, GFPuv-
HABP1Ala, GFPuv-HABP1Met proteins. 
The physicochemical properties of the his-tagged proteins are listed on Table 3.1. 
The protein bands of GFPuvHABP1, GFPuvHABP2, GFPuv-HABP1Ala, GFPuv-
HABP1Met and GFPuv were approximately at 28 kDa, compared to theoretical 
molecular weights (Table 3.1). 
Table 3.1: Reaction components for pMALc4x ligation. Physicochemical 
properties of the MBP-tagged proteins. 
Protein Number of amino acids pI MW (kDa) 
6His-GFPuv 250 6.26 28,327 
6His-GFPuv-HABP1 263 6.33 29.536 
6His-GFPuv-HABP2 263 6.26 29.478 
6His-GFPuv-HABP1Ala 261 6.33 29.329 
6His-GFPuv-HABP1Met 261 6 .33 29.329 
3.1.6 Molecular and structural characterization of GFPuv and GFPuv-HABP 
proteins 
3.1.6.1 Fluorescence Properties of the GFPuv and GFPuv-HABP Proteins 
Fluorescence properties of the fusion proteins were first examined under UV light. It 
has been observed that purified his-tagged GFPuv based proteins have fluorescence 
under UV light (Figure 3.18). 
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Excitation and emission properties of the proteins were analyzed by fluorescence 
spectroscopy. It has been demonstrated GFPuv-HABP fusion proteins have 
equivalent excitation (394 nm) and emission (510 nm) at the same wavelengths with 
similar intensities (Figure 3.19) as compared to that of GFPuv alone. This implies 
that fluorescence properties of GFPuv were protected upon the insertion of 
combinatorially selected peptide sequences. 
 
Figure 3.18 : Images of purified GFPuv-HABP1 protein under visible (A) and 
UV light (B). 
 
Figure 3.19 : Emission spectra for GFPuv, GFPuv-HABP1 and GFPuv-HABP2 
proteins. 
3.1.6.2 Binding of fusion proteins to HA surface 
The binding properties of GFPuv-HABP1, GFPuv-HABP2, GFPuv-HABP1Ala and 
GFPuv-HABP1Met proteins to HA surface were examined. GFPuv protein was used 
as negative control. Synthetic HA powder was incubated with the purified proteins. 
After washing steps, HA samples were examined with fluorescence microscopy. The 
construct with the strong binder sequence, i.e., GFPuv-HABP1 fusion, bound to the 
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HA particles with higher affinity than those of GFPuv-HABP2, GFPuv-HABP1Ala, 
GFPuv-HABP1Met and GFPuv (Figures 3.20 and 3.21). 
 
Figure 3.20 : Qualitative binding characterization of GFPuv, GFPuv-HABP1 and 
GFPuv-HABP2 proteins on HA powders. A, C, E the bright field 
images and, B, D, F the fluorescence images of the bound proteins, 
respectively. 
The effect of inorganic binding peptide molecular architecture on peptide binding has 
been assessed in previous studies. In these studies, the inorganic binding peptides 
selected from constraint peptide libraries were used (Choe et al., 2007; Seker et al., 
2007; Hnilova et al., 2008). 
It has been indicated that when the inorganic binding peptide retains its molecular 
conformation in both cyclic and linear forms, it also preserves similar adsorption 
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behavior on the surfaces. On the other hand, when the molecular structure of the 
respective sequence in the linear forms differs from their cyclic form, a decrease in 
the solid-binding affinities is observed. 
 
Figure 3.21 : Qualitative binding characterization of GFPuv-HABP1Ala and 
GFPuv-HABP1Met on HA powders. A, C the bright field images 
and B, D fluorescence images. 
In this study, the effect of inorganic binding peptide fused GFPuv protein molecular 
structure on its binding to inorganic surface was also demonstrated. While the fusion 
construct with the constraint strong binder sequence, i.e., GFPuv-HABP1, bound to 
the HA with high affinity, GFPuv-HABP protein with the linear strong binder 
sequence did not bind to HA surface.  
Both directions of the sequence, i.e., -N to- C or -C to -N (MLPHHGA or 
AGHHPLM) were assessed and determined that both constructs with linear strong 
binder HABP did not bind to HA powder. 
3.1.6.3 Quantitative binding characterization of the GFPuv and GFPuv-HABP 
proteins 
Quantitative binding characterization of the constructs, GFPuv, GFPuv-HABP1 and 
GFPuv-HABP2 was tested using QCM-D adsorption studies, carried out real time 
and recorded as a function of time. Each step on the sensograms represents the 
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addition of a higher concentration, as the plateaus represent the buffer rinse between 
the equilibrium conditions reached after addition of each concentration. The higher 
amount of protein deposited on the HA-coated QCM-D crystal results in a higher 
frequency shift. The frequency shift was detected at a very low level for GFPuv 
protein. This indicated that the GFPuv did not bind to HA surface. High level 
frequency shift resulted from the binding of the GFPuv-HABP1 on HA surface. 
GFPuv-HABP2 with a weak binder sequence resulted in a limited degree of binding 
(Figures 3.22 and 3.23). 
QCM-D data was utilized to calculate KD (desorption equilibrium constant) of the 
GFPuv-HABP1 and GFPuv-HABP2 fusion proteins. Simple Langmuir interaction 
model was used to describe the behavior of molecular adsorption. The frequency 
change is related to the adsorbed protein, i.e., ∆ƒ=(ƒmax x C) / (KD+C), where ∆ƒ 
represents the change in the frequency of the QCM-D at any given protein 
concentration and C is the corresponding protein concentration. To fit the Langmuir 
model to the experimental data, i.e., frequency shift versus protein concentration, the 
least-squared curve fitting was used, and from these, the ƒmax and KD values were 
extracted. The equilibrium binding constant of the GFPuv-HABP1 construct (6.6+0.3 
mol) was almost 70 times lower than that of the GFPuv-HABP2 (429+23 mol). 
These data indicated that GFPuv-HABP1 had a higher affinity to the HA substrate. 
 
Figure 3.22 : QCM-D signal change during the adsorption of GFP-HABP1 and 
GFP-HABP2 as a function of protein concentration. 
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Figure 3.23 : Overall QCM-D sensograms for the adsorption of GFPuv-HABP1, 
GFPuv-HABP2 and GFPuv on crystalline hydroxyapatite surfaces. 
3.1.6.4 Secondary structure of the proteins 
The CD spectra performed using a Jasco J-810 circular dichroism (CD) 
spectropolarimeter (Jasco, Easton, MD, USA) correspond to the dominating β-sheet 
structure in all cases resulting from the presence of the β-barrel core in the GFPuv 
(Figure 3.24).  
A change was observed in the amount of molar ellipticity possibly revealing a gain in 
GFPuv-HABP2, and a loss in GFPuv-HABP1, of protein structure. On the other 
hand, the variation in the molar ellipticity values did not correlate with the changes in 
fluorescence intensities of these constructs. GFPuv-HABP2 has almost doubled its 
molar ellipticity value compared to that of GFPuv, and the spatial orientation of the 
peptide might have caused a slight decrease in the GFPuv intensity (Figure 3.19). 
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Figure 3.24 : Elements of a neuron cell, adapted from Cetin (2003). Secondary 
structure analysis of GFPuv-HABP1, GFPuv-HABP2 and GFPuv 
proteins using CD, far-UW wavelength scan. 
3.1.7 Labeling synthetic and natural minerals 
3.1.7.1 Monitoring mineralization 
Time-wise mineralization was monitored by GFPuv-HABP1. HA crystals were 
formed on glass slides using an alkaline phosphate-based mineralization model 
(Gungormus et al., 2008). Using optical microscopy, it has been observed the amount 
of mineral on the glass slides increased linearly over time. 
The fluorescence imaging experiments of the glass slides labeled with GFPuv-
HABP1 resulted in an increase in the fluorescence intensity with the increasing 
mineral amount. However, the glass slides incubated with GFPuv exhibited no 
significant increase in fluorescence intensity as the amount of mineral was increased. 
Without HABP1 fusion partner, GFPuv was demonstrated to lack the mineral-
binding capability. As GFPuv was not able to specifically bind to the mineral 
surface, the non-specifically bound GFPuv was washed away from the surface upon 
the washing step. On the other hand, GFPuv-HABP1 fusion proteins with the mineral 
binding domain, facilitated a robust attachment of GFPuv onto HA surface and 
prevented resorption upon washing steps (Figure 3.25). 
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Figure 3.25 : Time-wise monitoring of mineralization. Increase in mineral 
coverage and the corresponding fluorescence microscopy images of 
the slides incubated with GFPuv and GFPuv-HABP1. Size bars 
correspond to 10 µm. 
The fluorescence microscopy measurements indicate a linear increase in intensity vs. 
the amount of mineral. All of the time-wise monitoring results show that the GFPuv-
HABP1 fusion protein has a potential utility for rapid and accurate monitoring of 
mineralization of HA. 
3.1.7.2 Labelling the biomineralized tissue 
The acellular afibrillar cementum, produced by cementoblasts, consists of a 
mineralized matrix, lacking collagen fibers and cementocytes. The binding ability of 
the GFPuv-HABP constructs on biomineralized samples was tested on human 
acellular afibrillar cementum. Cylindrical pieces cut from the acellular afibrillar 
cementum, close to the cemento-enamel junction were incubated with GFPuv, 
GFPuv-HABP1 and GFPuv-HABP2. Under the fluorescence microscope, samples 
incubated with neither GFPuv nor GFPuv-HABP2 displayed any contrast on teeth 
surfaces, while fluorescence contrast was observed in fluorescence imaging 
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experiments of the samples incubated with GFPuv-HABP1 (Figure 3.26). All of 
these data demonstrated that the GFPuv-HABP1 construct can recognize biologically 
mineralized tissues as well as synthetically formed HA. Fluorescence intensity 
measurements indicated that GFPuv-HABP1 fusion protein, containing the strong 
binder sequence, fluoresces greater than 6 fold on acellular afibrillar cementum 
samples, compared to those containing either GFPuv or GFPuv-HABP2 (Figure 
3.27). 
 76 
 
Figure 3.26 : Binding of (A) GFPuv, (B) GFPuv-HABP2 and (C) GFPuv-HABP1 
on acellular afibrillar cementum samples. Size bars correspond to 
100 µm. 
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Figure 3.27 : Average fluorescence intensities obtained from the acellular 
afibrillar cementum samples labeled with GFPuv, GFPuv-HABP2 
and GFPuv-HABP1. The values are normalized to the negative 
control with no protein incubation. 
3.2 Genetic Construction and Applications of MBP Tagged GFPuv and GFPuv-
Metal Binding Peptide Fusion Proteins 
In this part of the study, fusion proteins encoding GFPuv fluorescent protein and 
metal binding peptides selected by cell surface display have been engineered. It has 
been demonstrated the utility of gold-binging peptide AuBP2c and silver-binding 
peptide AgBP2c genetically fused to fluorescent protein GFPuv for site-specific 
immobilization of GFPuv protein onto gold and silver solid supports. Each fusion 
peptide was cloned into pMALc4x expression vector encoding N-terminal MBP tag. 
In pMALc4x expression system, the cloned gene is inserted down-stream from the 
malE gene of E. coli, which encodes maltose-binding protein (MBP), resulting in the 
expression of an MBP fusion protein (Maina et al., 1988, Url-6). The MBP expressed 
from pMALc4x has been engineered for tighter binding to amylose. pMAL 
expression system provides one-step purification of the fusion proteins using MBP’s 
affinity for maltose (Url-6). 
Combinatorially selected AuBP2c and AgBP2c peptides were fused to C-terminus of 
the GFPuv protein and the fusion peptide encoding sequence was cloned into MBP 
expressing vector pMALc4x. As a negative control, GFPuv was also cloned into the 
pMALc4x. Final engineered constructs were named as pMALc4x-GFPuv, 
pMALc4x-GFPuv-AuBP2c and pMALc4x-GFPuv-AgBP2c. 
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3.2.1 Designing GFPuv-metal binding peptide constructs 
In order to generate GFPuv, GFPuv-AuBP2c, and GFPuv-AgBP2c constructs, 
primers were designed according to amino acid sequence of AuBP2c (CGP-
WALRRSIRRQSY-GPC), AgBP2c (CGP-EQLGVRKELRGV-GPC), -SGGG linker 
and GFPuv. Multiple cloning site of pMALc4x has various restriction endonuclease 
cleavage sites including EcoRI and HindIII. GFPuv, GFPuv-AuBP2c and GFPuv-
AgBP2c encoding sequences were amplified using a series of forward and reverse 
primers containing extra residues including a EcoRI or HindIII site at their 5’ ends, 
respectively. As the pMALc4x expression vector encodes N-terminal MBP tag, in 
the final purified proteins, MBP tag was placed at the N- terminal, while in the 
AgBP2c and AuBP2c, it was located at the C- terminal. 
3.2.2 Obtaining PCR products encoding GFPuv and GFPuv-metal binding 
peptide fusion proteins 
The DNA fragment encoding GFPuv, GFPuv-AgBP2c and GFPuv-AuBP2c were 
obtained by single and consecutive PCR reactions, respectively. The GFPuv, GFPuv-
AgBP2c/AuBP2c PCR products should be approximately 730 bp, and 790 bp 
respectively. In the previous GFPuv-HABPs constructs pfu polymerase has been 
used. However, when sequence analyses were done at the end of the cloning, it has 
been observed that there were some point mutations in some of the constructs. 
Therefore, all the cloning steps were repeated to obtain the constructs without any 
mutation. Instead of pfu, Phusion High-fidelity DNA polymerase (NEB) was used to 
avoid mutation and prevent wasting time. For the first step PCR using Phusion High-
fidelity DNA polymerase (NEB), the annealing temperature for the fusion constructs 
was optimized at 50°C for 10 seconds. O’RangeRuler 50 bp DNA ladder (Appendix 
A1, Fermentas) was loaded into the agarose gel as a DNA marker. 
 After agarose gel electrophoresis, the molecular weight of GFPuv, GFPuv-AgBP2c 
and GFPuv-AuBP2c encoding DNA fragments were verified (Figures 3.28, 3.29, and 
3.30). 
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Figure 3.28 : Agarose gel image of GFPuv encoding DNA fragment amplified 
with Phusion High-fidelity DNA polymerase (NEB). 
 
Figure 3.29 : Agarose gel image of GFPuv-AgBP2c encoding DNA fragment 
amplified with Phusion High-fidelity DNA polymerase (NEB). 
 
Figure 3.30 : Agarose gel image of GFPuv-AuBP2c encoding DNA fragment 
amplified with Phusion High-fidelity DNA polymerase (NEB). 
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3.2.3 Cloning the target DNA into TOPO TA cloning vector 
Following the extraction of the PCR products from agarose gel, each purified DNA 
fragment was ligated into TOPO TA pCR2.1 TOPO (Invitrogen) cloning vector. 
pCR2.1 TOPO cloning vector has a single 3´ deoxythymidine (T) overhang for TA 
cloning. Taq polymerase adds a single deoxyadenosine (A) to the 3´ ends of PCR 
products through its nontemplate-dependent terminal transferase activity. Phusion 
High-fidelity DNA polymerase (NEB) was used to obtain GFPuv, GFPuv-AgBP2c 
and GFPuv-AuBP2c encoding DNA fragments. At the final extention step of the 
each PCR, taq polymerase was added to the reaction to obtain PCR products with a 
single deoxyadenosine (A) to the 3´ ends. 
After transformation of E. coli TOP10 F’ cells with the ligation product, colonies 
were observed on agar plates containing X-gal, IPTG and ampicillin. TOP10 F’ cells 
overexpress the Lac repressor (lacIq gene). IPTG was added to plates to obtain 
expression from the lac promoter in parallel with blue-white screening. Following 
transformation, blue and white colonies were observed on the agar plate (Figure 
3.31). 
 
Figure 3.31 : X-Gal, IPTG and ampicillin containing agar plate showing the blue-
white screening result for the TA cloning of GFPuv-AgBP2c 
encoding DNA fragment. 
3.2.3.1 Restriction endonuclease analysis 
White colonies were selected and pCP2.1 TOPO vectors harboring GFPuv, GFPuv-
AgBP2c and GFPuv-AuBP2c inserts were isolated from selected colonies. These 
plasmids were digested with EcoRI and HindIII to obtain the insert DNA fragments. 
Double digestion products were run in agarose gel (Figure 3.32).  
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Cloning of gfpuv, gfpuv-AgBP2c and gfpuv-AuBP2c fusion fragments was verified. 
The insert fragments obtained after the restriction digestion reaction were pufied for 
further cloning. 
 
Figure 3.32 : Verification of cloning of gfpuv-AgBP2c into TOPO TA cloning 
vector. Undigested and double digested recombinant TOPO 
plasmids harboring gfpuv-AgBP2c were loaded into the gel 
sequentially. 
3.2.4 Generating MBP tagged GFPuv protein and GFPuv-metal binding 
peptides fusion protein expressing bacteria 
Recombinant E. coli ER2507 strains expressing MBP-GFPuv, MBP-GFPuv-AgBP2c 
and MBP-GFPuv-AuBP2c were obtained by cloning each DNA fragment into 
pMALc4x expression vector and transforming the ER2507 bacteria with the 
constructs. 
3.2.4.1 Cloning into pMALc4x expression vector 
The pMALcx vector express the malE gene fused to the lacZα gene. Fusion protein 
encoding DNA fragment were inserted into restriction sites between malE and lacZα. 
In pMAL vectors, insertion inactivates the β-galactosidase α-fragment activity of the 
malE-lacZα fusion, resulting in a blue to white color change on Xgal plates when the 
construction is transformed into an α-complementing host (Url-6).  
In this study, the pMALC4x-GFP-GEPI fusion constructs were transformed into 
ER2507 host which have F- ara-14 leuB6 fhuA2 ∆(argF-lac)U169 lacY1 glnV44 
galK2 rpsL20 xyl-5 mtl-5 ∆(malB) zjc::Tn5(KanR) ∆(mcrC-mrr) genotype. The 
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malE gene is included in the malB deletion. Therefore, ER2507 strain does not 
produce any MBP from the chromosome. It also does not have the lacZ∆M15 allele, 
so it cannot be used for blue-to-white screening on X-gal plate (NEB pMAL protein 
purification and expression system, instruction manual). Cloning of gfpuv, gfpuv-
AgBP2c and gfpuv-AuBP2c fusion fragments into expression vector pMALc4x was 
verified by both restriction and sequence analyses. 
3.2.5 Production and purification of MBP tagged proteins under native 
conditions 
pMALc4x vector carries the lacIq gene, which codes for the Lac repressor. This 
keeps expression from “tac” promoter low in the absence of IPTG induction. 
Expression conditions were optimized for pMALc4x-GFPuv, pMALc4x-GFPuv-
AgBP2c and pMALc4x-AuBP2c constructs.  
It was observed that incubation of the culture at 30 oC for 6 hours after induction is 
ideal for expression of the multifunctional proteins. Following the expression, each 
E. coli ER2507 culture expressing the multifunctional proteins were examined under 
UV light (Figure 3.33). 
 
Figure 3.33 : E. coli ER2507 bacterial culture expressing MBP tagged GFP based 
fusion protein (right) and negative control E. coli ER2507 (left) 
under visible (A) and UV (B) light. 
The cloned genes were inserted into pMALc4x vector downstream from the MBP 
encoding malE gene. Hence, the fusion proteins were expressed with MBP tag. 
MBP-GFPuv, MBP-GFPuv-AgBP2c and MBP-GFPuv-AuBP2c proteins were 
purified by affinity purification specific for MBP tag (Figure 3.34).  
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The pMALc4x vector contains the sequence coding for the recognition site of 
apecific protease, i.e. Factor Xa, located just 5´ to the polylinker insertion sites. This 
recognition site allows MBP to be cleaved from the protein of interest after 
purification (Nagai and Thogersen 1987). Factor Xa cleaves after its four amino acid 
recognition sequence. This provides the attachment of few or no vector-derived 
residues to the cloned protein, depending on the site used for cloning (Url-6). In this 
study, EcoRI site was used for the cloning, so a few vector-derived residues were 
attached to the GFP-fusion protein. 
 
Figure 3.34 : GFP-GEPI (AuBP2c or AgBP2c) fusion proteins were expressed 
with MBP tag. Fusion proteins were purified by affinity purification 
specific for MBP tag (Adapted from Url-7). 
Following expression, purification and Factor Xa cleavage, the purity and molecular 
weights of fusion proteins were analyzed by SDS-PAGE (Figures 3.35 and 3.36). A 
single, purified band was observed for each protein of interest. 
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Figure 3.35 : SDS-PAGE analysis of purified, cleaved and uncleaved MBP-
GFPuv-AgBP and MBP-GFPuv proteins. 
 
Figure 3.36 : SDS-PAGE analysis of purified GFPuv-AuBP and GFPuv proteins. 
Following purification of MBP-GFPuv-AuBP and MBP-GFPuv 
fusion proteins, MBP tags were cleaved by Factor Xa and than 
removed by subsequent chromatography steps. 
The physicochemical properties of the purified proteins are listed on Table 3.2. 
While the protein bands of MBP-GFPuv, MBP-GFPuv-AgBP2c and MBP-GFPuv-
AuBP2c were approximately at 70 kDa, GFPuv, GFPuv-AgBP2c and GFPuv-
AuBP2c were at 30 kDa compared to theoretical molecular weights (Table 3.2) . 
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Table 3.2: Physicochemical properties of proteins expressing from pMALc4x. 
Protein Number of amino acids pI MW (kDa) 
MBP-GFPuv 629 5.33 69.764 
MBP-GFPuv-AgBP2c 651 5.39 71.903 
MBP-GFPuv-AuBP2c 651 5.55 72.111 
GFPuv 242 5.68 27.272 
GFPuv-AgBP2c 264 5.82 29.411 
GFPuv-AuBP2c 264 6.22 29.619 
3.2.6 Fluorescence properties of purified MBP-GFPuv, MBP-GFPuv-metal 
binding peptide proteins 
Excitation and emission properties of the purified proteins were analyzed by 
fluorescence. It has been demonstrated MBP tagged GFPuv-fusion proteins have 
equivalent excitation (394 nm) and emission (510 nm) at the same wavelengths with 
similar intensities (Figure 3.37) as compared to that of GFPuv alone. This implies 
that fluorescence properties of GFPuv were protected upon the insertion of GEPIs 
and fusion of MBP tag. 
 
Figure 3.37 : Emission spectra for GFPuv, MBP-GFPuv, MBP-GFPuv-AuBP2c 
and MBP-GFPuv-AgBp2c proteins. 
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3.2.7 Micropatterning of fluorescence fusion constructs 
Microcontact printing, one of the soft-lithography techniques, is an efficient 
technique for micropatterning of biomolecules (Ruiz and Chen 2007). Microcontact 
printing has been used by different groups to pattern biological materials, such as 
proteins (Bernard et al., 1998; Kacar et al., 2009a), DNA molecules (Lange et al., 
2004) and cells (Mrksich et al., 1997). 
The multifunctionality of the constructs created in this part of the study, was 
evaluated for fluorescence and noble metal binding characteristics using 
microcontact printing technique. The control experiments were carried out using 
MBP-GFPuv protein. 
Protein patterns were fabricated by taking advantage of the binding affinities of gold 
and silver binding peptide sequences of multifunctional MBP-GFPuv-AuBP2c and 
MBP-GFPuv-AgBP2c proteins. Using a soft lithography technique, is has been 
demonstrated that GEPI amino acid sequences of the MBP-GFPuv-GEPI fusion 
proteins can control the interaction of the multifunctional proteins with the noble 
metal surface. 
In the experiments for microcontact printing of protein samples on the inorganic 
surface, a fluorescence labeling procedure, like immune-staining process, is applied 
to visualized immobilized proteins on the surface by fluorescence microscope. In this 
study, using GFPuv fluorescence protein as a fusion partner for the multifunctional 
protein eliminated the fluorescence labeling step. 
MBP-GFPuv-AgBP2c, MBP-GFPuv-AuBP2c and MBP-GFPuv protein samples 
were patterned at 2 µM, 4 µM and 8µM concentrations. 
3.2.7.1 Microcontact printing of MBP-GFPuv-AgBP2c on silver substrate 
Protein patterned surfaces were prepared by directed stamping of MBP-GFPuv-
AgBP2c proteins to flat silver surface. The stamping procedure for microcontact 
printing of the MBP tagged fusion protein on silver surface is schematically 
represented in Figure 3.38. 
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Figure 3.38 : Schematics of micro-contact printing of MBP-GFPuv-AgBP2c 
fusion protein on flat silver surface. 
It has been observed that for each protein concentration, fluorescence contrast is 
significantly higher in the case of MBP-GFPuv-AgBP2 compared with MBP-GFPuv 
alone (Figures 3.39, 3.40 and 3.41). 
 
Figure 3.39 : FM images of patterning of 2 µM MBP-GFPuv-AgBP2c protein on 
flat silver surface via PDMS stamping. MBP-GFPuv, lacking the 
AgBP2c peptide, was used as a control. 
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It has also been observed that the higher concentration of the MBP-GFPuv-AgBP2c 
multifunctional proteins led the higher fluorescence intensity (Figures 3.39, 3.40 and 
3.41). This indicates that there is a correlation between the concentration of the 
multifunctional protein and the amount of the protein immobilized on the surface. 
 
Figure 3.40 : FM images of patterning of 4 µM MBP-GFPuv-AgBP2c protein on 
flat silver surface via PDMS stamping. MBP-GFPuv, lacking the 
AgBP2c peptide, was used as a control. 
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Figure 3.41 : FM images of patterning of 8 µM MBP-GFPuv-AgBP2c protein on 
flat silver surface via PDMS stamping. MBP-GFPuv, lacking the 
AgBP2c peptide, was used as a control. 
3.2.7.2 Microcontact printing of MBP-GFPuv-AuBP2c on gold substrate 
Protein patterns were prepared by directed stamping of MBP-GFPuv-AuBP2c 
proteins on flat gold surface. The stamping procedure for microcontact printing of 
MBP-GFPuv-AuBP2c on gold surface is schematically represented in Figure 3.42. 
 
Figure 3.42 : Schematics of micro-contact printing of MBP-GFPuv-AuBP2c 
fusion protein on flat gold surface. 
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The fluorescence microscopy results have shown that for each protein concentration, 
fluorescence contrast is significantly higher in the case of MBP-GFPuv-AuBP2 
compared to MBP-GFPuv alone (Figures 3.43, 3.44 and 3.45).The increasing 
concentration of the MBP-GFPuv-AuBP2c multifunctional proteins yielded 
increasing fluorescence intensity (Figures 3.43, 3.44 and 3.45). This data reveals that 
there is a correlation between the concentration of the multifunctional protein and the 
amount of the protein immobilized on the surface. 
 
Figure 3.43 : FM images of patterning of 2 µM MBP-GFPuv-AuBP2c protein on 
flat gold surface via PDMS stamping. MBP-GFPuv, lacking the 
AuBP2c peptide, was used as a control. 
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Figure 3.44 : FM images of patterning of 4 µM MBP-GFPuv-AuBP2c protein on 
flat gold surface via PDMS stamping. MBP-GFPuv, lacking the 
AuBP2c peptide, was used as a control. 
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Figure 3.45 : FM images of patterning of 8 µM MBP-GFPuv-AuBP2c protein on 
flat gold surface via PDMS stamping. MBP-GFPuv, lacking the 
AuBP2c peptide, was used as a control. 
3.2.8 Self-assembly of GFPuv-GEPI fusion proteins on nanoparticle-arrayed 
surface 
Following molecular construction, expression, purification and removal of MBP 
steps, GFPuv-AgBP2c and MBP-GFPuv-AgBP2c fusion proteins were immobilized 
on silver nanoparticle arrayed surfaces. Oriented immobilization of GFPuv-AgBP2c 
and MBP-GFP-GEPI fusion proteins on a noble metal surface was achieved. The 
control experiments were carried out using GFPuv and MBP-GFPuv proteins. 
Bifunctional AgBP-QBP peptide has been used as linker for the attachment of 
nanoparticles onto glass surface. GFPuv-AgBP2c and MBP-GFPuv-AgBP2c fusion 
proteins were immobilized on these patterned surfaces. The experimental procedure 
for immobilization of the GFPuv based fusion proteins on silver nanoparticle 
patterned surface is schematically represented in Figure 3.46. 
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Figure 3.46 : The procedure for self assembly of MBP-GFPuv-AgBP2c and 
GFPuv-AgBP2c fusion proteins on silver nanoparticle patterned 
surface. 
The multifunctionality of MBP-GFPuv-AgBP2c and GFPuv-AgBP2c were evaluated 
for fluorescence and silver binding characteristics using self assembly experiments. 
GEPI mediated self immobilization of functional proteins was applied to generate 
heterofunctional protein arrays.  
QBP-AgBP printed substrates were incubated with 80 nm and 20 nm AgNP. The 
micropatterns formed through microcontact printing of QBP-AgBP followed by 
silver nanoparticle assembly used as negative control. Surface, patterned with 80 nm 
silver nanoparticle was incubated with MBP-GFPuv-AgBP2c and MBP-GFPuv. 
Fluorescence microscopy was used for demonstrating the specific binding and 
multifunctionality of MBP-GFPuv-AgBP2c. It has been observed that only the 
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pattern incubated with MBP-GFP-AgBP fusion protein exhibits high contrast (Figure 
3.47).  
 
Figure 3.47 : Dark field and fluorescence images of the micropattern formed 
through PDMS stamping of QBP-AgBP followed by 80 nm silver 
nanoparticle assembly (negative control) and the micropatterns 
incubated with 15 µM MBP-GFPuv and MBP-GFPuv-AgBP2c 
proteins. 
The procedure was repeated using 20 nm silver particle to test specific binding of 
GFPuv-AgBP2c. Surface patterned with 20 nm silver nanoparticle was incubated 
with GFPuv-AgBP2c and GFPuv proteins. Using fluorescence microscopy, specific 
binding and bifunctionality of GFPuv-AgBP2c were demonstrated. It has been 
observed that only the pattern incubated with GFP-AgBP bifunctional protein 
exhibits high contrast (Figure 3.48). Immobilization data have shown that GFPuv-
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AgBP2cs have significantly higher binding affinity to silver compared to control 
GFPuv protein as a result of specific binding. The results have also shown that the 
immobilization of the GFP base fusion protein is material specific. Engineered 
proteins were immobilized onto silver nanopatterned surface; however, they did not 
bind to glass surface. 
 
Figure 3.48 : Dark field and fluorescence images of the micropattern formed 
through PDMS stamping of QBP-AgBP followed by 20 nm silver 
nanoparticle assembly (negative control) and the micropatterns 
incubated with 7.5 µM GFPuv and GFPuv-AgBP2c proteins. 
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3.2.9 Analysis of fluorescence quenching/enhancement assays on fusion protein 
bound NPs 
The multifunctionality of the GFPuv-GEPI fusion proteins was evaluated for 
fluorescence and noble metal binding characteristics also using fluorescence 
spectrophotometric measurements. 
Although the exact mechanism for the quenching by NPs has not been exhibited yet 
(Algar et al., 2009), some research groups have suggested that the efficiency of 
quenching by gold nanoparticles depends on the size and shape of the nanoparticle, 
distance from the fluorophore, spectral overlap and dipole orientation (Dulkeith et 
al., 2002; Dulkeith et al., 2005; Algar et al., 2009). 
The affinity of the bifunctional GFPuv-GEPI fusion proteins for colloidal noble 
metal nanoparticles was tested by quenching analyses using different sizes of 
nanoparticles. The correlation between the binding of bifunctional proteins to 
nanoparticles and quenching efficiency was evaluated. The samples were measured 
in microtiter plate through a fluorescence spectrophotometer at room temperature. 
3.2.9.1 Fluorescence quenching/enhancement by gold nanoparticles 
Fluorescence quenching due to the binding GFPuv-AuBP fusion protein to gold was 
tested on 2 nm, 5nm and 15 nm gold nanoparticles. The citrate-capped AuNPs (Ted 
Pella) and GFPuv-AuBP2 protein samples were mixed at different ratios and 
incubated for two hours. As the gold NP surface area for each NP size was increased, 
the higher quenching of GFPuv fluorescence was observed (Figures 3.49, 3.50 and 
3.51). 
In experiments using 15nm and 2nm gold NP, it has been observed that the GFPuv 
and GFPuv-AuBP displayed similar quenching characteristics with a decrease in 
fluorescence (Figures 3.49, 3.51). On the other hand, at 5 nm gold NP size, a 
difference in level of fluorescence quenching between GFPuv-AuBP and GFPuv is 
observed (Figure 3.50). 
 97 
 
Figure 3.49 : Fluorescence quenching/enhancement assay on GFPuv and GFPuv-
AuBP2c proteins bound to 15 nm AuNP. 
 
Figure 3.50 : Fluorescence quenching/enhancement assay on GFPuv and GFPuv-
AuBP2c proteins bound to 5 nm AuNP. 
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Figure 3.51 : Fluorescence quenching/enhancement assay on GFPuv and GFPuv-
AuBP2c proteins bound to 2 nm AuNP. 
Lapienc et al. (2010), have demonstrated that fluorescence of the fluorescence 
protein is quenched by 25 nm gold NP. Quenching is the decrease in the intensity of 
the fluorescence by a variety of mechanisms. In many fluorescence molecules the 
intensity primarily depends on the alterations in the efficiency of photon emission 
(Crowley et al., 1993). In addition, the intensity changes can be a result of changes in 
the absorbance that depends on pH, environment or other effects (Mercola et al., 
1972; Adkins et al., 1983). In this study, when NP is added to solution, GFPuv 
lacking the AuBP2c can be quenched by energy transfer. On the other hand, binding 
of AuBP2c part of fluorescence fusion protein can cause quenching by a different 
mechanism. 
Here, it can be suggested that specific binding of GFPuv-AuBP2c bifunctional 
protein to AuNPs may depend on physical characteristics of the NPs. 
3.2.9.2 Fluorescence quenching/enhancement by silver nanoparticles 
Binding of GFPuv-AgBP2c fusion protein to silver was demonstrated on 20 nm and 
80 nm silver nanoparticles. Quenching of fluorescence with binding of the protein to 
nanoparticles was evaluated as described in section 3.2.9.1. 
In the experiments with 20 nm silver NP, GFPuv and GFPuv-AuBP displayed similar 
quenching characteristics (Figure 3.52). On the other hand, at 80 nm silver NP size, a 
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difference in level of fluorescence quenching between GFPuv-AgBP and GFPuv. 
GFPuv-AgBP2c displayed a higher quenching ratio than that of GFPuv alone (Figure 
3.53). 
 
Figure 3.52 : Fluorescence quenching/enhancement assay on GFPuv and GFPuv-
AgBP2c proteins bound to 20 nm AgNP. 
 
Figure 3.53 : Fluorescence quenching/enhancement assay on GFPuv and GFPuv-
AgBP2c proteins bound to 80 nm AgNP. 
As discussed in section 3.2.9.2, specific binding of GFPuv-AgBP2c bifunctional 
protein to AgNPs may depend on the physical characteristics of NPs and a different 
mechanism can affect the quenching of GFPuv and GFPuv-AgBP2c proteins. 
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4.  CONCLUSION 
Molecular Biomimetics offers biological routes for the utilization of materials 
assembly and fabrication starting at the molecular scale. The proof of concept studies 
towards understanding the fundamentals and initiating the applications in bio-
nanotechnology are exponentially increasing over the years through the solid 
integration of molecular biology and materials sciences. Based on these studies, one 
can imagine that realization of truly green technologies is not very far away. In the 
scope of the thesis, the multifunctional protein based molecular constructs were 
designed for different applications varying from tissue engineering to controlling 
queching/enhancement properteis of metalic nanotructures.  
Inorganic binding peptides that were selected using combinatorial techniques became 
an important component of the majority of the bionanotechnological studies. Our 
group (Sarikaya and Tamerler) has been one of the first groups involved in the 
selection and re-engineering of peptides recognizing solid materials and using this 
property to fabrication of novel practical systems.  
In this study, heterofunctional fusion proteins were successfully produced through 
genetic conjugation of combinatorially selected solid binding peptides (HA binding 
peptide, silver binding peptide, gold binding peptide) to green fluorescent protein as 
multifunctional molecular probes for various applications such as monitoring 
inorganics formation, and assembly of nanoparticles. Using recombinant protein 
cloning and expression, and then purification techniques, GFP-GEPI based molecular 
constructs were produced. Heterofunctional fusion proteins were obtained in soluble 
form without any loss in original activities. Here, GEPIs are shown as effective 
fusion partners to link the inorganic recognition and binding property through 
controlling the biological and material interface without affecting the activity of the 
fusion partner. 
In biomedical application, tracking of HA formation can be achived by several 
methods, and it is very important. There have been various efforts on HA labelling, 
including synthesizing HA particles doped with fluorescent ions (de Araujo et al., 
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2007; Yang et al., 2008), synthesizing HA-quantum dot composites (Guo et al., 
2008; Hsieh et al., 2009). As an alternative and also more importantly as a targted 
method, here we develop HA labelling with biological fluorescence molecule. 
GFPuv-HABP1 fusion protein is the first molecule which can be used to 
functionalize HA surfaces for biomedical and biotechnological applications. GFPuv-
HABP1 bifunctional protein can be used as an efficient reporter to detect calcium 
phosphate mineral structures and as a real time agent for monitoring 
biomineralization processes.  
The structural studies of the engineered GFPuv-HABP proteins revealed that there is 
some degree of structural rearrangement following the insertion of the HABPs 
compared to the GFPuv alone. On the other hand, the GFPuv fluorescence of the 
fusion proteins was not result in significant changes. The QCM-D data indicated that 
GFPuv-HABP1 had granted the ability to bind to biomineral surfaces specifically. 
We also demonstrated the versatility of the GFPuv-HABP1 heterofunctional protein 
by carrying out time-wise monitoring of mineralization as well as visualization of 
mineralized tissues. 
Site-specific protein immobilization is required for the fabrication of efficient 
biotechnological tools such as enzymatic assays, protein chips, biosensors and 
microarrays (Bailey et al., 2007; Rusmini et al., 2007; Jung et al., 2008). The 
conventional immobilization methods may cause the uncontrolled assembly and a 
decrease in protein activity (Kwon et al., 2006; Rusmini et al., 2007). Here, inorganic 
binding peptides were demosntrated for the controlled immobilization and patterning 
of GFPuv and MBP-GFPuv on silver and gold surface. The heterofunctionality of 
MBP-GFPuv-AuBP2c/AgBP2c and GFPuv-AuBP2c/AgBP2c genetically fused 
proteins were demonstrated fluorescence and noble metal binding characteristics 
using soft lithogpraghy techniques such as microcontact printing, self immobilization 
methods and fluorescence spectrophotometry.  
Patterning and directed assembling of MBP-GFPuv-GEPI and GFPuv-GEPI fusion 
proteins has revealed that this multifunctional proteins may be used as a fluorescence 
ink for various applications in the field of bionanotechnology. Generally speaking, 
the specific and high-affinity binding of MBP-GFPuv-AgBP2c/AuBP2c and GFPuv-
AgBP2c/AuBP2c heterofunctional proteins on the nanopatterned and flat surface 
indicate that several nanoplatforms may be fabricated using these fusion proteins. 
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Quenching of the fluorescence upon binding of the protein to nanoparticles was also 
evaluated. Fluorescent measurements have shown that the higher the total surface 
area of gold nanoparticles yielded the lower fluorescence intensity. This may 
indicates that the decrease in the intensity is proportional to the binding of the 
bifunctional protein to nanoparticle. Effects of binding GFPuv-AuBP fusion protein 
to gold, on fluorescence quenching/enhancement were tested on 2 nm,  5nm and 15 
nm gold nanoparticles.  
A difference in the fluorescence quenching level between GFPuv-AuBP and GFPuv 
was observed only in the case of 5 nm gold. In adition, binding of GFPuv-AgBP2c 
fusion protein to silver was demonstrated on 20 nm and 80 nm silver nanoparticles. 
The difference in the quenching level was observed only in the case of 80 nm silver 
nanoparticle. In a previous study, it has been shown that the fluorescence of the 
fluorescence protein is quenched by gold nanoparticle (Lapienc et al., 2010). A 
variety of mechanisms lead to quenching, therefore GFPuv and GFPuv-
AuBP2c/AgBP2c may be quenched by different mechanisms. The specific binding of 
GFPuv-AuBP2c/AgBP2c bifunctional proteins may depend on physical 
characteristics of the nanoparticles. Further studies with different size and ratio of 
metal nanoparticles and with different GFPuv-GEPI constructs may provide a 
biologically controlled sensing moities based on fluorescence 
quenching/enhancement assays based on the binding of the fusion proteins to 
nanoparticles.  
Taken together, based on the previous studies on the biocombinatorially-selected and 
characterized hydroxyapatite binding peptides (Gungormus et al., 2008), HABP1, 
HABP2, AgBP2c (Hnilova et al, unpuslished data) and AuBP2c (Hnilova et al., 
2008) fusion proteins were created using GFP as a fluorescence protein partner. 
Throughout the study, various heterofunctional proteins were obtained: GFPuv-
HABP1, MBP-GFPuv-AgBP2c, MBP-GFPuv-AuBP2c, GFPuv-AgBP2c and 
GFPuv-AuBP2c. These proteins have a potential for utilization in imaging studies, 
fabrication of new materials and systems for biotechnological and biomedical 
applications. In addition, the plasmid constructs encoding these heterofunctional 
proteins can be further engineered to add new functionalities to create 
technologically promising multifunctional proteins based platforms. Many 
biocombinatorially selected peptides can enable inorganic synthesis, such as gold, 
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silver, silica, calcium carbonate, and magnetite. Variuos GFPuv-GEPI constructs can 
be generated and therefore extended their applicability in the monitoring and probing 
the assembly and formation of materials. 
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Figure A.1 : DNA Markers (Fermentas).  
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Figure A.2 : Protein Molecular Weight Marker (Fermentas). 
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